Skip to main content
PLOS Biology logoLink to PLOS Biology
. 2023 Jul 17;21(7):e3002189. doi: 10.1371/journal.pbio.3002189

Structural and biochemical characterization of the key components of an auxin degradation operon from the rhizosphere bacterium Variovorax

Yongjian Ma 1,#, Xuzichao Li 1,#, Feng Wang 2,#, Lingling Zhang 1, Shengmin Zhou 3, Xing Che 3, Dehao Yu 4, Xiang Liu 5, Zhuang Li 2,*, Huabing Sun 4,*, Guimei Yu 1,*, Heng Zhang 1,*
Editor: Cara Helene Haney6
PMCID: PMC10374108  PMID: 37459330

Abstract

Plant-associated bacteria play important regulatory roles in modulating plant hormone auxin levels, affecting the growth and yields of crops. A conserved auxin degradation (iad) operon was recently identified in the Variovorax genomes, which is responsible for root growth inhibition (RGI) reversion, promoting rhizosphere colonization and root growth. However, the molecular mechanism underlying auxin degradation by Variovorax remains unclear. Here, we systematically screened Variovorax iad operon products and identified 2 proteins, IadK2 and IadD, that directly associate with auxin indole-3-acetic acid (IAA). Further biochemical and structural studies revealed that IadK2 is a highly IAA-specific ATP-binding cassette (ABC) transporter solute-binding protein (SBP), likely involved in IAA uptake. IadD interacts with IadE to form a functional Rieske non-heme dioxygenase, which works in concert with a FMN-type reductase encoded by gene iadC to transform IAA into the biologically inactive 2-oxindole-3-acetic acid (oxIAA), representing a new bacterial pathway for IAA inactivation/degradation. Importantly, incorporation of a minimum set of iadC/D/E genes could enable IAA transformation by Escherichia coli, suggesting a promising strategy for repurposing the iad operon for IAA regulation. Together, our study identifies the key components and underlying mechanisms involved in IAA transformation by Variovorax and brings new insights into the bacterial turnover of plant hormones, which would provide the basis for potential applications in rhizosphere optimization and ecological agriculture.


Plant-associated bacteria play important regulatory roles in modulating levels of the plant hormone auxin, affecting the growth and yields of crops. This study reveals the molecular mechanism by which the bacterium Variovorax uses proteins encoded by a novel gene cluster to degrade auxin.

Introduction

Auxin is a vital phytohormone in plants, affecting almost all the aspects of plant’s life. In the meristems, auxin functions as a regulator of cell division, elongation, and differentiation, determining the growth and architectures of shoots and roots [1]. Indole-3-acetic acid (IAA) is a highly abundant, natively synthesized auxin in plants. IAA is not uniformly distributed but instead locally synthesized and transported directionally via the polar distributed PIN and PIN-like transporters in plants [2,3]. The resultant IAA concentration gradients instruct plant development and are therefore dedicatedly regulated in synthesis, inactivation, and degradation [46].

Plants are associated with millions of microorganisms. The plant–microbiota interaction serves as an important layer of auxin gradient regulation, tuning plant development, phenotypes, and fitness [7,8]. For instance, most rhizobacteria are found capable of producing IAA [7,9], which works in conjunction with IAA synthesized in plants to stimulate the growth of primary and lateral roots within an optimal concentration range but cause root growth inhibition (RGI) at higher concentrations [7,10]. Apart from the IAA-synthesizing bacteria, some plant-associated bacteria could also degrade IAA [7,11], which could serve as a down-regulating scheme of both bacterially produced and endogenous IAA to fine tune the IAA concentration gradients. Elucidating the underlying mechanism of bacterial IAA regulation would help to maximize the beneficial effects of auxin production or degradation for ecological agriculture [1214]. Two gene clusters, iac and iaa, were previously discovered responsible for aerobic and anaerobic degradation of IAA, respectively [15,16].

More recently, a new auxin degradation operon has been reported for strains of Variovorax, which actively guides IAA degradation and readily counteracts RGI induced by bacterially produced IAA in plant microbiomes [14], indicating distinguishing root growth promoting traits of the Variovorax strains. Variovorax is a gram-negative bacteria genus in the family Comamonadaceae, commonly found in the rhizosphere and regulating IAA levels [17]. The auxin IAA degradation (iad) operon is found highly conserved among strains of Variovorax and unique to the Variovorax genus [14,18]. However, transformation of non-IAA-degrading bacteria, such as Acidovorax root219, with genomic fragments of the iad operon could generate gain-of-function strains, capable of IAA degradation and rescuing RGI [14]. Notably, the iad operon shares limited homology with the iac and iaa gene clusters, representing a new auxin IAA-degradation pathway. Dissecting and defining the functional mechanism of auxin degradation by Variovorax is therefore of significant importance for potential applications in ecological and stress agricultures [11].

In this study, we have focused on 10 genes around an overlapped region of 2 genomic fragments of iad operon (Figs 1A and S1A), which were found sufficient for enabling IAA degradation and/or RGI reversion when transformed to non-IAA-degrading bacteria [14]. Using biochemical and structural approaches, we have elucidated the molecular mechanism of IAA transformation by the Variovorax operon. Two proteins, IadK2 andIadD, were found to directly associate with IAA. IadK2, featured with a two-lobed structure, was identified as an ATP-binding cassette (ABC) transporter solute-binding protein (SBP) that binds specifically and strongly with IAA, most likely mediating IAA uptake from the environment. Combined biochemical, structural, and mass spectrometry studies revealed that IAA was transformed to the biologically inactive 2-oxindole-3-acetic acid (oxIAA) by the two-component IadC-IadD/IadE dioxygenase-reductase system encoded by the iad operon in Variovorax. This is consistent with a latest report published during the preparation of this manuscript [18]. Further, we demonstrated that such an IAA-degradation property of Variovrax could be transplanted to Escherichia coli by the transformation of a minimum gene set containing iadC/D/E. Together, our results uncover the major underlying molecular mechanism of IAA turnover by a new auxin degradation gene cluster in Variovorax, providing guidance for potential plant microbiota manipulation and optimization for ecological farming.

Fig 1. IadK2 encoded by the Variovorax iad operon selectively binds with auxin IAA.

Fig 1

(A) Schematics for the auxin IAA-degradation (iad) operon in Variovorax paradoxus CL14. Ten genes ranging from IMG gene ids 2643613661–2643613670 are illustrated. (B) Chemical structures of IAA and auxin analogs. IAA is the most dominant natural auxin in most plants. Other endogenous or synthetic auxins or analogs such as 4-Cl-IAA, IBA, IPA, NAA, and 2,4-D are also displayed. (C) ITC measurement of IAA binding to iadk2. The binding isotherm for iadk2-IAA is biphasic, revealing 2 dissociation constants. Three independent measurements were performed and the Kd values are shown as mean ± SEM. (D) ITC measurements of auxin analogs to iadk2. The binding of other auxins and analogs to iadk2 is distinct from IAA with a single-phase isotherm and substantially reduced binding affinity. ND: no binding detected. Kd values are shown as mean  ±  SEM from 3 or more independent measurements. (E) TSA for iadk2 with IAA and analogs. The orthogonal TSA experiments were performed for iadk2 with different auxins and analogs to further determine the binding specificity. Three replicates of each TSA experiments were performed. Error bars represent the standard deviations. Source data for C–E can be found in S1 Data. IAA, indole-3-acetic acid; IBA, indole-3-butyric acid; IPA, indole-3-propionic acid; ITC, isothermal titration calorimetry; NAA, 1-naphthylacetic acid; TSA, thermal shift assay; 4-Cl-IAA, 4-chloroindole-3-acetic acid.

Results

IadK2 directly associates with IAA

To understand the molecular mechanism of IAA turnover by Variovorax iad operon, we first set out to identify the components responsible for IAA binding (Fig 1A and 1B). SBPs located in the periplasm work in concert with ABC transporters to transport a variety of compounds into bacteria [19,20]. The iad operon is predicted to encode 2 SBPs, IadK2 and IadK3 (Figs 1A and S1A), which could potentially mediate the uptake of IAA in the rhizosphere. To determine whether IadK2 and IadK3 could bind with IAA, we expressed and purified the proteins for isothermal titration calorimetry (ITC) measurements. IadK2 could engage IAA with nanomolar affinity, whereas no obvious binding was detected for IadK3 and IAA (Figs 1C and S1B). To further understand the specificity of IadK2, we also tested the binding of IadK2 with other endogenous and synthetic auxins including 4-chloroindole-3-acetic acid (4-Cl-IAA), indole-3-butyric acid (IBA), indole-3-propionic acid (IPA), 1-naphthylacetic acid (NAA), and 2,4-dichlorophenoxyacetic acid (2,4-D) (Fig 1B). IadK2 could bind with most bicyclic analogs but not the single aromatic ring 2,4-D, indicating a preference for bicyclic compounds (Fig 1D). To test this hypothesis, we further measured the binding between IadK2 and phenylacetic acid (PAA) composed of a single aromatic ring and found indeed no binding between IadK2 and PAA (S2A Fig). Additionally, IadK2 associates with the bicyclic auxins and analogs with substantially reduced affinities in comparison to IAA (Fig 1D), suggesting the specificity of IadK2 for IAA. This is further supported by the results of the thermal shift assay (TSA), where IAA displayed the most significant stabilization effect on IadK2 (Fig 1E). Interestingly, neither IAA nor the auxin analogs could bind to IadK3 (S1B and 1C and S2B Figs), suggesting a distinct substrate specificity for IadK3. Together, these data suggest that IadK2 is an IAA-specific SBP in Variovorax. The high affinity of IadK2 for IAA may facilitate efficient IAA uptake by Variovorax from the environment [2123].

Structural basis for IAA engagement by IadK2

SBPs are classified into 7 clusters (A-F) based on the structural similarities [20]. To further understand the IAA binding by IadK2, we next solved the crystal structure of IadK2 at a resolution of 2.3 Å (S1 Table). IadK2 is composed of 2 rigid domains, Domain 1 and Domain 2, connected by a flexible hinge region (Fig 2A and 2B). Both domains possess the α/β fold, consisting of a central β-sheet flanked by α-helices (Fig 2B). The hinge region comprises 3 linkers (L1–L3) with 2 α-helices in linker L2, resembling SBPs in the subcluster B-III (S3A–S3C Fig), which are usually associated with type I ABC transporters for aromatic acids uptake [19,20]. Consistently, Dali search revealed a B-III SBP from Rhodopseudomonas palustris in complex with caffeic acid as the closest structural homology of IadK2 [24] (S3C Fig).

Fig 2. Structure of IadK2 and the IAA-binding pocket.

Fig 2

(A) Domain organization of iadk2. Iadk2 is composed of 2 domains, Domain 1 and Domain 2. (B) Crystal structure of iadk2. Iadk2 features a two-lobed structure with Domain1 and Domain 2 connected by a linker region. L1–L3 indicate the 3 linkers connecting the 2 lobes of iadk2. Such overall structural features and that L2 contains 2 α helices group iadk2 to the B-III subcluster of sbps. The same color scheme in A is applied. (C) Structure of iadk2 complexed with IAA calculated from docking and MD simulation. A similar substrate pocket at the interface of the 2 lobes of iadk2 was predicted, resembling other sbps. The right panel displays the calculated IAA-binding pocket. Iadk2 is colored in gray and IAA is shown as yellow sticks. Key residues potentially involved in IAA binding are shown in sticks representation. (D) ITC measurements of IAA binding to iadk2 mutants. ND: no binding detected. Weak binding: KD > 100 μM. Kd values are shown as mean ± SD from 3 or more independent measurements. (E) TSA for iadk2 mutants and IAA. Three replications of each TSA experiments were performed. Data are presented as mean  ±  SEM. Source data for D and E can be found in S1 Data. IAA, indole-3-acetic acid; ITC, isothermal titration calorimetry; MD, molecular dynamics; TSA, thermal shift assay.

As co-crystallization or crystal soaking with IAA failed after extensive attempts, we therefore performed the docking and molecular dynamics (MD) simulation analysis to understand the interaction between IAA and IadK2 (Fig 2C). An IAA-binding pocket at the interface of domain 1 and domain 2 was predicted. Notably, the computed IAA-bound structure is in a “closed” conformation in comparison to our substrate-free crystal structure (Fig 2B and 2C), suggesting IadK2 might switch from a resting “open” conformation to a “closed” conformation upon ligand binding. Small-angle X-ray scattering (SAXS) analysis also supported the “closed” conformation for IAA-bound IadK2 (S3D Fig). This is analogous to the ligand-induced “Venus Fly-trap”-like closure observed for other SBPs [25]. Next, mutagenesis studies were performed to validate the predicted pocket. Most tested mutations reduced or almost abolished the binding to IAA (Fig 2D and 2E). Particularly, substitutions of Phe168, Trp172, Arg199, Phe308, and Tyr311 significantly compromised IAA binding (Fig 2D and 2E). Phe168 and Phe308 are conserved among SBPs in the B-III cluster. Trp172 and Arg199 are moderately conserved but Tyr311 is more variable among B-III SBPs (S3E Fig).

IadK3 shares approximately 70% sequence identity with IadK2. To elucidate why IadK3 fails to bind IAA, we predicted the structure using AlphaFold2 [26]. As revealed, IadK3 and IadK2 share significant structural similarity (S3B Fig). Structural comparison revealed several residues located in the binding pocket in IadK2 are not conserved in IadK3, such as Trp172, Ser104, Thr125, and Asn126 in IadK2 (S3A, S3B and S3E Fig). Supporting the importance of these residues in defining IAA binding, replacements with corresponding residues in IadK3 obviously impaired the binding of IadK2 with IAA (Fig 2D and 3E). Notably, the double mutation replacing both Trp172 and Ser104 with those of IadK3 (W172L/S104V) completely abrogated the binding of IAA. Therefore, Trp172 and its neighboring residues such as Ser104, Thr125, and Asn126 may play important roles in determining IadK2 specificity for IAA.

Fig 3. Characterization of the IadD/Enon-heme Rieske dioxygenase complex.

Fig 3

(A) ITC measurement of IAA binding to the E complex. Kd values are shown as mean  ±  SEM from 3 or more independent measurements. (B) Crystal structure of iadd/E. Upper panel: Domain organization of iade and iadd. Bottom: one heterodimer of iadd and iade in the asymmetric unit. Iadd is composed of 2 domains. The catalytic domain of iadd is colored in light blue and the Rieske domain is colored in pale cyan. Positions of the ferrous iron in the catalytic domain and the [2Fe-2S] cluster in the Rieske domain are indicated. The iade is a single domain protein and is colored in pale green. (C) The 2.6 Å cryo-EM density of the iadd/E complexed with IAA. A mushroom-shaped, heterohexameric structure was resolved. The top and side views are displayed. (D) Overlay of the apo and IAA-bound structures of iadd/E. The IAA-bound heterohexamer of iadd/E (colored by subunits) was superimposed with that of the apo state generated with crystal symmetry-equivalent copies (colored in gray). No significant conformational changes were identified except some regions at the crystal-packing interfaces. The inset panel shows a zoom-in view of the active site composed of the [2Fe-2S] cluster, the mononuclear iron and the substrate-binding pocket. (E) The IAA-binding pocket in iadd. The indole ring of IAA and the mononuclear iron are in relatively perpendicular orientation. Key residues in the IAA-binding pocket are shown as sticks. (F) ITC measurements of IAA binding to iadd mutants. Mutations of residues in the IAA-binding pocket as shown in E disrupted the binding. ND: no binding detected. Source data for A and F can be found in S1 Data. IAA, indole-3-acetic acid; ITC, isothermal titration calorimetry.

Characterization of the IadD/IadE heterocomplex

Apart from IadK2, IadD could also directly bind with IAA, whereas other proteins encoded by the iad operon did not (Figs S1D, S1E, and S4A). Sequence analysis suggested genes iadD and iadE may encode the large and small subunits of an aromatic-ring-hydroxylating dioxygenase, respectively. Indeed, IadD and IadE co-migrated in gel filtration assay roughly in a 1:1 molar ratio (S4B Fig). Consistently, the IadD/E complex directly binds IAA with a Kd value of about 17 μM (Fig 3A).

To further understand the structural features of the IadD/E complex, we determined the crystal structure at a resolution of 1.8 Å (Fig 3B and S1 Table). Dali search revealed the biphenyl dioxygenase from Burkholderia xenovorans LB400 as the closest homolog [27], which is a Rieske non-heme iron dioxygenase. The Rieske non-heme iron dioxygenases, typically composed of α and β subunits that are equivalent to IadD and IadE, respectively, share a conserved α3β3 configuration [28]. Data from the analytical ultracentrifugation analysis IadD/E also supported a heterohexamer model in solution (S4C Fig), indicating IadD/E may share the same α3β3 configuration.

IadD features a Rieske domain (residues 44–160) and a catalytic domain (residues 1–43 and 161–437) (Fig 3B). The catalytic domain contains a core helix-grip fold with an eight-stranded antiparallel β-sheet surrounded by 10 helices. The Rieske domain folds into 2 parallel β-sheets composed of 3 and 4 β-strands, respectively, which are connected by multiple long loops. IadE is a single-domain protein, containing a twisted seven-stranded β-sheet and 3 α-helices, which may mainly serve as a scaffold protein contributing to proper assembly of the oligomeric enzyme complex.

To understand the binding of IAA with IadD, we then determined a 2.6 Å cryo-EM structure of IadD/E complexed with IAA (S7 Fig and S2 Table). An overall mushroom-shaped heterohexamer composed of 3 IadE at the “stem” and 3 IadD in the “cap” was resolved (Fig 3C). The active site of IadD is located at the interface of IadD subunits, composed of a Rieske [2Fe-2S] cluster from the Rieske domain and a mononuclear iron in the catalytic domain of a neighboring subunit (Figs 3D and S5A and S5B). The [2Fe-2S] is stabilized by contacts with Cys85, His87, Cys106, and His109 and the mononuclear iron coordinates with His216, His221, and Asp377. Adjacent to the mononuclear iron is the IAA-binding pocket lined by polar and hydrophobic residues including Asn210, Leu211, His216, His221, Phe251, His311, Lys322, Arg329, and Tyr362 (Figs 3E and S5A and S5B). No profound overall conformational changes were observed for IadD/E after binding of IAA (Figs 3D and S5C). The side chain of His311 in IadD is relocated to accommodate the binding of IAA (S5D Fig). The mononuclear iron and the coordinating residues also move slightly inwards (about 1.6 Å) following the binding of IAA. The resolved IAA-binding pocket of IadD/E is largely superimposed with that of biphenyl in the biphenyl dioxygenase structure, but contains different residues to accommodate the substrate specificity (S6A Fig). As anticipated, mutation of residues in the pocket abrogated IAA binding (Fig 3F). These results therefore suggest IadD/E is a Rieske non-heme dioxygenase, which may use IAA as a substrate.

IadD/IadE and IadC reconstitute a two-component dioxygenase system specific for IAA transformation

The Rieske dioxygenases usually work in combination with a reductase or both reductase and ferredoxin components, forming a two- or three-component dioxygenase system, to oxidize substrates [28]. Indeed, analysis of the iad operon revealed the neighbor gene iadC that encodes a reductase protein (IadC) (Figs 1A and S1A). To test if IadC could work together with IadD/E to transform IAA, we purified the IadC protein and performed the in vitro IAA transformation experiment. Indeed, IAA was transformed efficiently in the presence of both IadD/E and IadC, whereas neither IadD/E nor IadC alone could catalyze the transformation (Fig 4A and 4B), suggesting a potential two-component dioxygenase system for IAA conversion.

Fig 4. Reductase IadC and dioxygenase IadD/E catalyze IAA transformation.

Fig 4

(A) IAA transformation assay. Purified iadd/E and iadc were used to test the in vitro IAA transformation. The amounts of IAA were quantified using the Salkowski reagent and adsorption at 530 nm. Data are presented as mean  ±  SEM. (B) Time and concentration dependence of IAA transformation by iadc and iadd/E. IAA mixed with the Salkowski reagent show pink color, which turned colorless after treatment with iadc and iadd/E. Top panels show the color change of IAA reaction mixtures in the presence of Salkowski reagent over time (left, 0.7 μM iadc/D/E enzymes) or concentrations of iadc/D/E (right, reacted for 30 min), from pink to colorless. Below graphs illustrate the changes of quantified IAA amounts (adsorption at 530 nm) over time (left) or enzyme concentrations (right). (C) The determined crystal structure of iadc. Iadc possesses a tri-lobed structure, consisting of 3 domains including FBD, NBD, and fesd. The [2FE-2S]-binding pocket in fesd and the FMN-binding pocket in FBD are displayed, with key residues participated in the binding indicated. (D) Effects of iadc mutations on IAA transformation. In vitro IAA transformation assay was performed with both WT and mutated iadc in the presence of iadd/E. Data are presented as mean  ±  SEM. (E) Schematic illustration of the functional cooperation of iadc and the iadd/E. Iadc transfers electron to the active site of iadd composed of [2Fe-2S] and ferrous iron to catalyze IAA transformation. The inset panel displays key residues in iadd surrounding the [2Fe-2S] cluster and the ferrous iron, potentially essential for the electron transfer. (F) Effects of iadd mutations on IAA transformation. Both WT iadd/E and mutants defective in substrate binding or electron transfer were tested with the in vitro IAA degradation assay. Data are presented as mean  ±  SEM. Source data for A, B, D, and F can be found in S1 Data. FBD, FMN-binding domain; IAA, indole-3-acetic acid; NBD, NADH-binding domain; WT, wild type.

Next, we determined the crystallographic structure of IadC at a resolution of 1.68 Å (S1 Table). The overall triangle-shaped protein is composed of 3 major domains, including an FMN-binding domain (FBD, residues 1–115), an NADH-binding domain (NBD, residues 116–238), and a plant-type [2Fe-2S] cluster domain (FeSD, residues 239–329) (Fig 4C). The FBD folds into a six-stranded β-barrel and the NBD features an α/β fold, forming a five-stranded β-sheet wrapped by helices. FMN resides at the interface of the FBD and NBD domains, with the isoalloxazine ring sandwiched between the side chains of His59 and Phe233 and anchored by polar contacts with nearby residues. Further, the ribityl moieties of FMN are stabilized by polar contacts with residues Arg58, Arg89, and Ser92 (Fig 4C, right panel). FeSD is composed of a twisted β-sheet with an α-helix positioned at each side. The [2Fe-2S] cluster is coordinated by 4 Cys residues in 2 peripheral loops, facing the center of the tri-lobbed IadC (Fig 4C, bottom panel). IadC closely resembles the phthalate dioxygenase reductase (PDR) from Pseudomonas cepacia according to Dali analysis [29] (S6B Fig), indicating a classical IA FMN-type reductase. However, the relative domain orientations are distinct between the 2 structures. While FBD and NBD are closely packed in both PDR and IadC structures, FeSD associates primarily with NBD in IadC but with FBD in the PDR (S6C Fig), potentially representing the different states of electron transfer [28].

Mutagenesis studies were then performed to further confirm the functional role of IadC in IAA transformation. FMN is thought to mediate electron transfer from the NADH electron donor to the [2Fe-2S] electron acceptor, which further delivers the electrons to the dioxygenase for the catalysis reaction [29,30] (Fig 4C and 4E). As anticipated, mutation of residues involved in FMN binding compromised IAA turnover (Fig 4D). Similarly, the C279S mutation impairing coordination of the [2Fe-2S] cluster significantly decreased the efficiency of the reaction. Likewise, mutation of residues involved in electron transfer and IAA binding in IadD also significantly impaired the processing of IAA (Figs 3E and 4E and 4F), supporting the critical role of the catalytic activity of IadD in IAA transformation.

In addition to IAA, other auxin analogs also play essential roles in plant growth and development. We therefore further examined whether the IadD/E-IadC system could transform IAA analogs. While 4-Cl-IAA was transformed with reduced efficiency, IadD/E-IadC could not catalyze the turnover of IAA analogs such as IBA and IPA (S8A and S8B Fig). Thus, the IadD/E-IadC dioxygenase system appears to be selective for the transformation of IAA.

Metabolite identification of IAA degraded by the IadD/E-IadC dioxygenase system

Next, we set out to identify the product of IAA transformed by this new dioxygenase system. To this end, we performed the high-performance liquid chromatography (HPLC) and the high-resolution mass spectrometry (HRMS) analyses. IAA was treated in vitro with the IadD/E-IadC enzymes till complete consumption of IAA. The reacted mixture was first denatured and analyzed using HPLC. A new peak with a retention time of 5.4 min was observed accompanied with the disappearance of the IAA peak (Figs 5A and S9). Fractions from this potential product peak were then collected and subjected to the HRMS analysis (Fig 5B). Two possible products were proposed based on the HRMS spectra, including the 5-hydroxy indole-3-acetic acid (5-HIAA) and the oxIAA. IAA develops the pink color with the Salkowski reagent [31], which turned colorless after transformation by IadD/E-IadC (Fig 4B), indicating a product unreactive with Salkowski reagent. It therefore ruled out 5-HIAA as the potential product as that a dark gray color was observed after mixing 5-HIAA with the Salkowski reagent and 5-HIAA could be further degraded by IadD/E-IadC (Figs 5C and S8). By contrast, oxIAA was found unable to react with the Salkowski reagent (Fig 5C). Furthermore, the product peak overlapped with that of oxIAA and the peak intensity increased following the addition of oxIAA to the reacted mixture in the HPLC assays (S9 Fig); the adsorption spectrum of the reacted mixture also overlaid with that of oxIAA (Fig 5D), both supporting oxIAA as the product.

Fig 5. The IadD/E-IadCdioxygenase-reductase system converted IAA to oxIAA.

Fig 5

(A) HPLC analysis of IAA before (in pink) and after transformation (in blue) by iadd/E-iadc. (B) HRMS analysis of the transformed products of IAA by iadd/E-iadc. The elution for potential product peak in HPLC was collected and analyzed by HRMS. Characteristic peaks for oxiaa were identified, which agreed with the calculated mass. Source data for A and B can be found in S1 Data. (C) Color development of IAA and analogs in Salkowski reagent. The listed compounds (0.5 mm) developed different colors after mixing with the Salkowski reagent. (D) The absorbance spectra of IAA, oxiaa, and the products by iadd/E-iadc. The spectrum scan for IAA, oxiaa, and transformed IAA by the iadd/E-iadcafter mixing with the Salkowski reagent was performed. (E) The mechanism of IAA transformation by iadd/E-iadc. The iadd/E-iadcdioxygenase system catalyzes the incorporation of oxygen atoms to IAA from O2, leading to the formation of 2-hydroxyindole-3-acetic acid, which potentially primarily exist as the stable “keto” form, oxiaa. HPLC, high-performance liquid chromatography; HRMS, high-resolution mass spectrometry; IAA, indole-3-acetic acid.

Domains of IadD/E and IadC would reconstitute the electron transport chain of Rieske dioxygenase, where electrons from NADH in NAD are passed to the [2Fe-2S] cluster by FMN bound to FAD of IadC followed by transporting to the active site of IadD through the [2Fe-2S] clusters of IadD/E, catalyzing the incorporation of oxygen atoms of O2 into IAA [2830,32]. Indeed, in the isotopic experiment with 95% H2O18 and 16O2, we found most oxIAA with m/z = 192.0655 containing 16O-bearing amide, indicating the oxygen was from 16O2 (S10 Fig). Together, these data suggest that IAA was converted to oxIAA by the dioxygenase system composed of the IadD/E dioxygenase and the IadC reductase (Fig 5E). Interestingly, a recent study also reported the catalyzed conversion of IAA to 2-hydroxyindole-3-acetic acid intermediate by the iad operon in bacteria [18], which is chemically unstable and would form the stable “keto” form, oxIAA, as shown in our study.

Engineering of E. coli for IAA transformation

We next explored the possibility of engineering non-IAA-degrading bacterial strains for IAA transformation. Vectors containing different combinations of genes for iadK2, iadD/E, and iadC were generated and transformed to E. coli to evaluate the IAA conversion capabilities (Fig 6A). Indeed, we found transformation of the iad genes to E. coli could enable bacterial IAA conversion. Consistent with the in vitro assay, iadC, iadD, and iadE were required for IAA transformation by E. coli. Nevertheless, IadK2 appeared to be dispensable, as E. coli could efficiently transform IAA regardless of the presence of IadK2 under the experimental condition (Fig 6B), indicating the potential presence of endogenous IAA transporters in E. coli. Consistently, the loss-of-function mutations in IadD or IadC significantly compromised or abrogated IAA conversion by the engineered E. coli, whereas mutation of IadK2 showed no obvious effect on IAA transformation (Figs 6C and S11). These results therefore suggest that incorporation of a minimum set of genes containing IadE, IadD, and IadC to E. coli could enable bacterial transformation and inactivation of IAA.

Fig 6. Ectopic expression of Variovorax genes iadC/D/E enables bacterial transformation of IAA by E. coli.

Fig 6

(A) Schematic for the design of the experiment for the bacterial IAA transformation assay. Vectors containing the indicated iad genes were transformed to E. Coli and the transformation of IAA in the LB medium was monitored using the Salkowski reagent. (B) In vivo IAA transformation assay for E. coli containing different iad genes as indicated in A. Little IAA transformation was observed when the empty vector carrying no iad genes was transformed to E. coli. The presence of all 3 genes iadc/D/E resulted in efficient IAA transformation. (C) Effects of Iad proteins mutants in the in vivo IAA transformation by E. coli. Loss-of-function mutations of iadk2 (S104V/W172L), iadd (H216A), and iadc (C279S) were tested. Minimal IAA transformation occurred with the empty vector or in the absence of protein expression inducer IPTG. Source data for B and C can be found in S1 Data. (D) Schematic diagram of IAA transformation by the Variovorax iad operon. IAA transported to the bacterial cell would be first processed by the iadd/E-iadc dioxygenase system and converted to oxiaa in the presence of molecular oxygen, thereby deactivating the auxin IAA. Despite not required for the engineered E. coli, iadk2 may mediate the efficient IAA uptake by Variovorax from the environment. However, further studies would be required to examine whether iadk2 is need for Variovorax IAA degradation. IAA, indole-3-acetic acid; IPTG, isopropyl-β-D-thiogalactoside.

Discussion

Bacterial degradation of plant hormone plays an important role in regulating plant hormone levels [8,16]. Recently, a conserved iad operon coding for a new auxin IAA degradation pathway was discovered among strains in the genus Variovorax, which is responsible for reversing the RGI and promoting plant growth [14]. Here, we identified and characterized the proteins produced by the iad operon, directly involved in the processing of auxin IAA. Our study suggests IAA could be transformed to oxIAA by an Rieske non-heme dioxygenase system constituted by IadD/E and IadC encoded by the iad operon (Fig 6D). As oxIAA is biologically inactive [4], products of the iadC/D/E genes are likely sufficient for the bacterial down-regulation of IAA in the rhizosphere to reverse RGI. Indeed, a latest study published during the preparation of this manuscript also reveals the same minimum gene set for IAA inactivation and the reversion of RGI [18]. Interestingly, gene iadC was found strictly required in some bacterial strains but dispensable in others, indicating that the function of IadC may be (partially) compensated by other reductase proteins in the latter. Notably, the IadD/E-IadC catalyzed IAA conversion to oxIAA is reminiscent of IAA inactivation in plants by the plant protein dioxygenase for auxin oxidation (DAO) [33], which is the dominant catabolic pathway in plant for IAA concentration regulation.

In addition to the IadD/E-IadC proteins, we also found IadK2 may also contribute to the IAA-degradation pathway of Variovorax by facilitating IAA transportation, although it was found dispensable for E. coli (Fig 6B). The iad operon encodes 2 SBPs that are located between the outer and inner membranes of gram-negative bacteria and typically required for nutrient and signaling molecules uptake by the ABC transporters [34], IadK3 and IadK2. Both IadK3 and IadK2 belong to the B-III subclass of SBPs with a binding specificity for aromatic compounds [20]. Despite the significant structural and sequence similarities, the 2 SBP proteins have different ligand specificity. While IadK3 show no detectable binding, IadK2 binds to IAA with nanomolar affinity. Considering the high binding affinity and the micromolar concentrations of IAA in the environment [2123], IadK2 may serve as a highly efficient IAA “grasper,” working with ABC transporter in the membrane and mediating IAA uptake in Variovorax. This property may contribute to the supreme capability of Variovorax strains in degrading IAA and reverse RGI [14,17]. IadK2 also binds with other auxins with structural similarities such as 4Cl-IAA, NAA, IPA, and IBA, despite the substantially reduced affinity (μM or lower). IadK3 however show no binding with these auxin analogs. Interestingly, we found IadK3 could weakly associate with oxIAA. The detailed roles of IadK3 and IadK2 in the Variovorax auxin degradation pathway, however, remain to be further characterized and defined.

IadD and IadE form a heterohexameric non-heme Rieske dioxygenase. IadC is an FMN-type reductase, which transfers electrons from the donor NADH to the active site of IadD to catalyze the incorporation of oxygen atoms into IAA for the production of oxIAA. This may represent the first step in the bacterial degradation of IAA by the iad operon. The IadD/E-IadC dioxygenase system appears to be specific for IAA (S8 Fig), similar to the ligand specificity of IadK2, indicating the preference for IAA for the iad operon pathway. The biologically inactive oxIAA is a major form of the irreversible oxidation in plants regulating IAA levels [5]. The IadD/E-IadC-catalyzed conversion of IAA to oxIAA is therefore likely the most essential step in IAA degradation and RGI reversion of plants. Recently, the 2-hydroxyindole-3-acetic acid was reported as the first-step intermediate in the metabolite analysis of Variovorax paradoxus CL14 cultured in the presence of IAA [18]. It should be noted that the 2-hydroxyindole-3-acetic acid as an “enol” is chemically unstable, which would be converted into the stable “keto” form, oxIAA (the major tautomer) if no further degradation occurs as shown in our study. Inside bacteria, the intermediates would likely be further degraded to anthranilic acid in the iad pathway [18]. The elucidated molecular mechanism underlying the most essential step in IAA degradation by the iad operon, could be translated for applications in engineering and optimizing the rhizosphere microbiome [35,36]. For example, we have demonstrated that incorporation of a minimum gene set containing iadC/D/E could enable E. coli to degrade IAA. Further studies are required to elucidate the functional roles of other components in this pathway and the underlying mechanism of the following decomposition.

Methods

Protein expression and purification

DNA sequences for genes in Variovorax paradoxus CL14 iad auxin degradation operon were subcloned into expression vectors for protein purification. Genes encoding IadK3 (IMG gene ID: 2643613661), IadK2 (IMG gene ID: 2643613662), and IadG (IMG gene ID: 2643613666) were inserted into pET28-SUMO vector, and sequences for IadH-J (IMG gene IDs: 2643613663–2643613665), IadE-F (IMG gene ID: 2643613667, 2643613668), and IadC (IMG gene ID: 2643613670) were cloned into pET28-MHL vector. Two constructs for IadD (IMG gene ID: 2643613669) were generated by subcloning to vectors pET28-SUMO and 13S-A (Addgene, 48323) vectors, respectively. The resultant plasmids were transformed into Rosetta DE3 cells for protein expression. IadE and IadD were co-expressed to obtain the functional complex. Protein expression was induced with isopropyl-β-D-thiogalactoside (IPTG) at OD600 of 0.6 and 37°(. Cell pellets were resuspended in the binding buffer (25 mM Tris-HCl (pH 7.5), 500 mM NaCl, 5 mM imidazole, and 2 mM β-mercaptoethanol) and broken by sonication. Ni-NTA resins (Qiagen) were added and incubated with the cleared lysate at 4° for 1 h before being extensively washed with the washing buffer (binding buffer supplemented with 15 mM imidazole). Target protein was eluted with the elution buffer containing 300 mM imidazole. The expression tags were removed by TEV protease. Tag-free proteins were concentrated and loaded onto the HiTrap SP column (Cytiva) for further purification. Gel-filtration was performed at the last step of purification on a ÄKTA Pure system with running buffer containing 25 mM Tris-HCl (pH 7.5), 150 mM NaCl, 2 mM dithiothreitol (DTT). Peak fractions were collected and concentrated for use. Mutant proteins were purified in the same way as described above.

Isothermal titration calorimetry (ITC)

ITC experiments were performed using a MicroCal PEAQ-ITC system (Malvern). All the experiments were performed at 25°P in a buffer containing 25 mM Tris-HCl (pH 7.5) and 150 mM NaCl (unless otherwise stated). A typical titration experiment involved 18 injections of IAA solution (500 to 2,000 μM) into the cell containing protein of interest (30 to 100 μM) with a time spacing of 120 s. Data was analyzed using the MicroCal PEAQ-ITC analysis software. All the measurements were repeated at least 2 times.

Thermal shift assay (TSA)

TSA was performed to examine the binding of Iad proteins with IAA and analogs. Ligands concentrations were tested at 2- to 100-fold excess (10 to 1,000 μM) relative to the proteins (5 μM). The fluorescence dye SYPRO Orange at a final of 200-fold dilution was used to monitor the unfolding of proteins. The protein and ligand were incubated for 10 min at room temperature before the addition of SYPRO Orange dye. The QuantStudio 1 Plus real-time PCR system (Thermo Fisher) was used to control the temperature increasing from 25°1 to 99°t with an increment of 0.5°n and to monitor the fluorescence (excitation: 520 ± 10 nm and emission: 558 ± 10 nm). Each tested group was run in triplicate and repeated. Data was imported to the Protein Thermal Shift software for analysis and plotting.

Gel-filtration assay

The gel-filtration assay for the IadD/IadE complex was carried out using the HiLoad 200 column (Cytiva). IadD/E purified by the cation exchange chromatography was concentrated to 20 mg/ml and loaded into the column pre-equilibrated with the running buffer containing 25 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 2 mM DTT. The peak fractions were collected and analyzed with SDS-PAGE.

Analytical ultracentrifugation analysis

The purified IadD/E complex sample was diluted to 0.5 mg/ml using the sample buffer containing 25 mM Tris-HCl (pH 7.5) and 150 mM NaCl and subjected to the sedimentation velocity measurements using an Optima XL-I analytical ultracentrifuge (Beckman-Coulter). Data was analyzed with the SEDFIT and SEDPHAT programs [37,38].

Small-angle X-ray scattering

The IadK2-IAA complex was concentrated to 20 mg/ml in a buffer containing 25 mM Tris-HCl (pH 7.5), 280 mM NaCl, and 2 mM DTT. SAXS data was collected on beamline BL19U2 at Shanghai Synchrotron Radiation Facility (SSRF) with a Pilatus detector. One-dimensional intensity curves were obtained by the ATSAS package [39,40]. SAXS data processing and analysis were carried out using PRIMUS software within the ATSAS package [41]. Distance distribution and molecular weight were obtained from GNOM [42]. Ab initio modeling and low-resolution 3D shape envelopes reconstruction were performed by DAMMIF [43]. CRYSOL and SREFLEX were used to test the fit quality of reconstructed models with the experimental SAXS profiles [40].

In vitro IAA and analogs transformation assay

In vitro assay was performed to test the capability of IadC/D/E enzymes encoded by the iad operon in transforming IAA and analogs. The reaction mixture was composed of 100 mM Tris-HCl (pH7.5), 250 μM reduced NADH, 10 μM ammonium iron (II) sulfate, and 3 μM of each enzyme component. The reaction was initiated by the addition of IAA substrate (0.1 to 0.5 mM) at room temperature (unless otherwise stated). The mixture was vortexed periodically to introduce oxygen for the reaction and was boiled to stop the reaction. After pelleting the precipitants, the supernatant was collected and mixed with 2 volumes of Salkowski reagent made of 0.5 M ferric chloride and 35% perchloric acid for the quantification of residual substrate by measuring the adsorption at 530 nm.

HPLC and HRMS analysis of IAA metabolite

The reacted mixture with almost all the IAA substrate consumed from the in vitro IAA transformation assay was denatured by heat and the supernatant was collected for HPLC analysis on a Shimadzu LC-40 HPLC machine equipped with an InertSustain 5 μM C18 HPLC column (4.6 × 250 mm). The UV detection was carried out at 260 nm, following separation using water (solvent A) and methanol (solvent B) as mobile phase with a linear gradient elution at a flow rate of 0.8 ml/min as follows: 0 to 5 min, 5% B; 5 to 15 min, 10% B; 15 to 20 min, 50% B; 20 to 22 min, 50% B; 22 to 25 min, 95% B; 25 to 33 min, 95% B. The peak fraction with a retention time of about 5.4 min was collected and re-dissolved in water containing 10% methanol after removing the solvent under vacuum. HRMS was performed with an LTQ-Orbitrap mass spectrometer (Thermo Fisher). Pure IAA, NADH, NAD+, and oxIAA were also analyzed with HPLC for comparison and identification of peaks. The isotopic experiment was carried out in the solution containing 95% H2O18 as well as 16O2 in the air following the same protocol as described above.

IAA bacterial transformation assay

Variovrax iad genes IadK2, iadC/D/E were transformed to E. coli BL21(DE3) to screen for the minimum set required for IAA transformation. The E. coli cells were cultured in the LB medium till OD600 of 0.6 at 37°3 and IPTG was then added to induce Iad proteins expression. Two h later, 0.2 mM IAA was added to the medium and the cells were grown for 16 h, during which culture aliquots were collected and the amounts of IAA were determined using the Salkowski reagent and the adsorption at 530 nm.

Crystallization, data collection, and structure determination

Purified adK2, IadD/E complex, and IadC were concentrated to 15 to 20 mg/ml. Protein crystallization was performed by mixing 1 μl of protein solution with 1 μl of the crystallization buffer using the sitting drop method. Crystals of IadK2 protein were grown in a reservoir solution containing 27% w/v polyethylene glycol 3,350, 0.1 M Tris (pH 8.60); 1 M cobalt (II) chloride hexahydrate. IadD/E crystals were obtained at 18°E in a reservoir solution containing 28% (v/v) 2-methyl-2,4-pentanediol, 0.05 M sodium cacodylate trihydrate (pH 6.0), 0.05 M magnesium acetate tetrahydrate, 40% (v/v) 1,3-propanediol. Crystals of IadC protein were grown at 18°p in a reservoir solution containing 0.1 M Bis-tris propane (pH 7.1), 1.2 M sodium malonate (pH 7.0), 0.1 M calcium chloride dihydrate. Crystals were cryo-protected in the mother liquor supplemented with 20% glycerol before flash-frozen in liquid nitrogen for data collection.

X-ray diffraction datasets were collected at beamline BL19U1 of Shanghai Synchrotron Radiation Facility (SSRF). Structure determination was performed by CCP4I2 package [44]. Structure of IadK2 was determined by molecular replacement using a predicted model from Alphafold2 [26]. Structure of the IadD/E protein complex was solved by molecular replacement using the crystal structure of toluene 2,3-dioxygenase (PDB ID:3EN1). Initial model improvement was performed manually in COOT [45]. Model refinement was performed by phenix.refine [46,47] and CCP4I2 package [44]. Data processing and structural refinement statistics are shown in the S1 Table.

Docking and molecular dynamics (MD) simulation

Docking and MD simulation analysis were performed to define the binding site of IAA in IadK2. The initial binding pocket was selected by referring to the homologous structure (PDB ID: 4FB4). Molecular docking of IAA anion to the potential binding site was performed using AutoDock Vina [48]. The revealed initial binding pose served as the start point for MD simulation. MD simulations were performed using the OpenMM and Ambertools software packages [49,50]. The anion IAA was modeled using the generalized Amber force field, and the protein structures were modeled using the Amber14SB force field [51]. The protein-ligand complexes were solvated with TIP3P water molecules in a cubic box with a length of 12.0 Å, and sodium or chloride ions were added to neutralize the systems. For all the simulations, all the bonds that involved hydrogen atoms were constrained and the Langevin dynamics thermostat was applied to keep the temperature at 300 K.

Cryo-EM sample preparation, data collection, and structure determination

Purified IadD/E complex was incubated with 20-fold molar excess IAA. Aliquots of 4 μL samples were applied to glow-discharged holey carbon girds (Cu, R1.2/1.3, 300 mesh, Quantifoil). The grids were blotted with force 2 for 3 s and plunged into liquid ethane using a Vitrobot (FEI Thermo Fisher). Cryo-EM data were collected with a Titan Krios microscope (FEI) operated at 300 kV and images were collected using EPU at a nominal magnification of 105,000× (resulting in a calibrated physical pixel size of 0.85 Å/pixel) with a defocus range from −1.2 μM to −2.2 μM. The images were recorded on a K3 summit electron direct detector (Gatan). A dose rate of 15 electrons per pixel per second and an exposure time of 2.5 s were used, generating 40 movie frames with a total dose of approximately 54 electrons per Å2. A total of 2,122 movie stacks were collected (S2 Table).

The movie frames were imported to RELION-3 [52]. Movie frames were aligned using MotionCor2 [53] with a binning factor of 2. Contrast transfer function (CTF) parameters were estimated using Gctf [54]. Particles were auto-picked and extracted from the dose-weighted micrographs. The following steps, including 2D classification, generation of initial model, 3D classification, and 3D refinement, were performed in cryoSPARC [55]. A total of 1,717,755 particles were selected after 2D classification for further processing. Heterogeneous refinement was performed with the 3 initial models to distinguish different conformational states. 3D refinement was performed with C1 symmetry for the selected class representing the intact complex, after confirming that the IAA molecule is present in all the copies of the IadD/E complex. A second round of 3D refinement with C3 symmetry was performed, converging at a resolution of 2.59 Å.

The map was sharpened using Phenix Autosharpen tool [5658]. The apo IadD/E crystallographic structure (S1 Table) was used as the initial template. Manual adjustments and refinements were performed with Coot [45]. Iterative real-space refinement was then performed in Phenix using phenix.real_space_refine [57]. The quality of the model was analyzed with MolProbity in Phenix [59]. Refinement statistics are summarized in S2 Table.

Supporting information

S1 Fig. Interaction between Iad proteins and IAA (related to Figs 1 and 3).

(A) Schematics for the auxin IAA-degradation (iad) operon in Variovorax paradoxus CL14. The green box highlights the 10 genes examined in the study for IAA transformation. (B) ITC measurement of IAA binding to iadk3. “ND” indicates no binding detected. (C) Thermal shift assay for iadk3 with IAA and different analogs including 4Cl-IAA, IPA, IBA, 2,4-D, and NAA. Three replicates of each TSA experiments were performed. (D) Integrated heat plots for ITC measurements of different Iad proteins binding with IAA. Measurements for proteins iadf-J and iadc with IAA are displayed. ND: no binding detected. Three or more independent measurements were performed. (E) Tm changes for Iad proteins in the presence of IAA in the thermal shift assay. Three replications of each TSA experiments were performed. While adding of IAA substantially increased the melting temperature of iadk2, no profound effects were observed for the rest. Source data for B–E can be found in S1 Data.

(TIF)

S2 Fig. ITC measurements of PAA to IadK2 and IadK3 (related to Figs 1 and 2).

(A) Integrated heat plots for ITC measurement of iadk2 binding with PAA. ND: no binding detected. (B) Integrated heat plots for ITC measurements of IadK3 binding with PAA. ND: no binding detected. Two or more measurements were performed. Source data can be found in S1 Data.

(TIF)

S3 Fig. Comparison of IadK2, IadK3, and B-III SBPs (related to Fig 2).

(A) The overall structure and the calculated IAA-binding pocket of iadk2 using docking and MD simulation. The L2 linker is colored in pink and the rest is in pale green. Key residues interacting with IAA are shown in sticks representation. (B) Structure of iadk3 predicted using alphafold2. The L2 linker is colored in green and the rest is in cyan. The counter residues of iadk2 involved in IAA binding iniadk3 are indicated. Residues labeled in magenta are not conserved between iadk3 and iadk2, which could be related to the IAA specificity of iadk2. (C) The closest structural homolog of iadk2 according to the Dali search. The structure of an SBP from Rhodopseudomonas palustris in complex with caffeic acid (DHC) is displayed (PDB: 4FB4). The structure containing 2 α helices in L2 belongs to the B-III subcluster of sbps. Key residues involved in substrate DHC binding are shown. (D) SAXS analysis of iadk2 complexed with IAA. Left panel: overlaid scattering pattern of the SAXS ab initio model (pink line), the theoretical scattering profiles of iadk2-IAA complex structure from MD simulation (green line) and iadk2 apo crystal structure (blue line) with SAXS scattering data of iadk2-IAA complex. The inserted panel displays the P(r) distance distributions. Right: Superposition of the ab initio SAXS model (shown as sphere) and the iadk2-IAA complex structure from MD simulation. Source data for D can be found in S1 Data. (E) Multiple sequence alignment. Sequences of iadk2, iadk3, and B-III sbps including Bp0622 (Uniprot Q7VS30), Rpb4630 (Uniprot Q2IR47), Rpd1889 (Uniprot Q139W5), and Rpa1789 (Uniprot Q6N8W4) were aligned with Clustal Omega. Essential residues for iadk2 IAA binding are marked with the filled triangles, among which the strictly conserved residues were shaded in blue, whereas moderately and less conserved residues were in yellow and light green, respectively.

(TIF)

S4 Fig. Biochemical and structural characterization of IadD/E complex (related to Fig 3).

(A) ITC measurements of IAA binding to iadd or iade protein alone. ND: no binding detected. Left panel: no binding between iade and IAA was detected. Right panel: a fitted Kd value of 24 μM was obtained for iadd and IAA. Source data for A can be found in S1 Data. (B) Size-exclusion chromatograms of iadd and iade. The elution fractions from the complex peak were analyzed by SDS-PAGE gel (lower panel). Uncropped SDS-PAGE gel image can be found in S1 Raw Image. (C) Sedimentation coefficient distributions of iadd/E complex.

(TIF)

S5 Fig. Structural comparison of apo and IAA-bound IadD/E complex (related to Fig 3).

(A) Electron densities and the atomic model around the active site of apo iadd/E. Densities and models around [2Fe-2S], Fe and the substrate-binding pocket were shown. (B) Electron densities and the atomic model around the active site of IAA-bound iadd/E. (C) Structural comparison of the apo and IAA-bound iadd/E structures. For clarity, 1 heterodimer subunit is displayed. The apo structure is colored in white and IAA-bound structure is colored by proteins. No profound overall conformational changes were identified between the apo and the IAA-bound structures. (D) A zoom in view of c around the active site. The side chain of H311 in IadD is relocated to accommodate the binding of IAA. Fe and coordinating residues also move slightly inwards (about 1.6 Å) following the binding of IAA.

(TIF)

S6 Fig. Structural comparison of IadD/E and IadC with homolog structures (related to Figs 3 and 4).

(A) Structural comparison of iadd/E-IAA with the homolog structure (PDB: 5AEW). For clarity, a single heterodimer is displayed. Overall, the 2 structures superimposed well with each other, despite some difference in the relative orientation of the α and β subunits. The inset panel in the right shows the detailed insight into the superimposed substrate-binding pocket. (B) The homolog structure of iadc (PDR, PDB: 2PIA). The structure of PDR is also composed of 3 major domains, NBD, FBD, and fesd. Ligands FMN and the [2Fe-2S] cluster are indicated. (C) Structural comparison of IadC with PDR. PDR is colored in white and IadC is colored by domains. The arrows indicate the relative domain rotations of IadC in comparison to PDR.

(TIF)

S7 Fig. Cryo-EM data processing for IadD/E in complex with IAA (related to Fig 3).

(A) A representative raw cryo-EM micrograph. Scale bar: 50 nm. (B) Representative 2D class averages. (C) 3D classification. Class 1 represent the bad reconstruction. Class 2 represents the broken protein complex. Class 3 represents the intact protein complex. (D) The final cryo-EM map of 3D refinement on Class 3. (E) Viewing distribution of the 3D refinement. (F) The Fourier shell correlation (FSC) curve of the reconstruction. The 0.143 gold standard FSC cutoff was used to determine the final resolution.

(TIF)

S8 Fig. Transformation of IAA and analogs by IadC-IadD/E (related to Figs 4 and 5).

(A) Color development of IAA and analogs with the Salkowski reagent before and after treatments with iadc-iadd/E. (B) Quantification of the relative amounts of IAA or analogs before and after the oxidation reaction catalyzed by the iadc-iadd/E system. Three replications of each condition were performed. Data are presented as mean ± SEM. Source data for B can be found in S1 Data.

(TIF)

S9 Fig. IAA metabolite analysis by HPLC (related to Fig 5).

The reacted mixture (RM) was analyzed with HPLC. Analyses for NADH, NAD, IAA, and oxIAA were also performed to assign the peaks.

(TIF)

S10 Fig. HRMS spectrum of isolated degradation product (oxIAA) from the isotopic experiment (related to Fig 5).

The in vitro IAA degradation reaction with IadC-IadD/E was carried out in the solution containing 95% H2O18 (v/v).

(TIF)

S11 Fig. IAA transformation by E. coli transformed with IadK2/C/D/E genes (related to Fig 6).

Effects of Iad proteins mutants in the in vivo IAA transformation by E. coli. Two vectors, v1 (containing genes IadK2 and IadC) and v2 (with genes IadD and IadE), were transformed to E. coli BL21(DE3) to enable IAA transformation. Mutants of IadK2 (W172L, R199A), IadD (H221A), and IadC (S61A) were tested. Little IAA conversion was observed with the empty vector without the iad genes or with the loss-of-function mutations in iadC or iadD. Source data can be found in S1 Data.

(TIF)

S1 Table. Crystallographic data collection and refinement statistics.

(DOCX)

S2 Table. Cryo-EM data collection, refinement, and validation statistics.

(DOCX)

S1 Data. Source data for graphs in this paper.

(XLSX)

S1 Raw Image. Uncropped SDS-PAGE gel image in this paper.

(PDF)

Acknowledgments

We thank the staffs from the BL17B/BL18U1/BL19U1/BL19U2/BL01B beamlines of the National Facility for Protein Science (NFPS) at Shanghai Synchrotron Radiation Facility for assistance in crystallographic data collection. The cryo-EM data was collected using the Cryo-Electron Microscopy Facility of Hubei University. We thank Prof. Jeffery L. Dangl for critical reading and useful comments.

Abbreviations:

ABC

ATP-binding cassette

CTF

contrast transfer function

DAO

dioxygenase for auxin oxidation

FBD

FMN-binding domain

HPLC

high-performance liquid chromatography

HRMS

high-resolution mass spectrometry

IAA

indole-3-acetic acid

IBA

indole-3-butyric acid

IPA

indole-3-propionic acid

IPTG

isopropyl-β-D-thiogalactoside

ITC

isothermal titration calorimetry

NAA

1-naphthylacetic acid

NBD

NADH-binding domain

MD

molecular dynamics

PAA

phenylacetic acid

PDR

phthalate dioxygenase reductase

RGI

root growth inhibition

SAXS

small-angle X-ray scattering

SBP

solute-binding protein

TSA

thermal shift assay

2,4-D

2,4-dichlorophenoxyacetic acid

4-Cl-IAA

4-chloroindole-3-acetic acid

5-HIAA

5-hydroxy indole-3-acetic acid

Data Availability

The atomic coordinates of the structures have been deposited in the Protein Data Bank under accession codes 7YLT (IadK2), 7YLS (IadD/E), 7YLR (IadC) and 8H2T (IadD/E-IAA). The cryo-EM map of IadD/E in complex with IAA has been deposited to the Electron Microscopy Data Bank under the corresponding accession code EMD-34443. Source data are available in S1 Data.

Funding Statement

This work was supported by the National Natural Science Foundation of China (32071218 to H.Z.; 32200496 to G.Y.; 22007072 to H.S. and 32201004 to Z.L.) and the Ministry of Science and Technology, 2022YFA0911800 to Z.L.. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Brumos J, Robles LM, Yun J, Vu TC, Jackson S, Alonso JM, et al. Local Auxin Biosynthesis Is a Key Regulator of Plant Development. Dev Cell. 2018;47(3):306–18 e5. Epub 20181025. doi: 10.1016/j.devcel.2018.09.022 . [DOI] [PubMed] [Google Scholar]
  • 2.Grieneisen VA, Xu J, Maree AF, Hogeweg P, Scheres B. Auxin transport is sufficient to generate a maximum and gradient guiding root growth. Nature. 2007;449(7165):1008–13. doi: 10.1038/nature06215 . [DOI] [PubMed] [Google Scholar]
  • 3.Barbez E, Kubes M, Rolcik J, Beziat C, Pencik A, Wang B, et al. A novel putative auxin carrier family regulates intracellular auxin homeostasis in plants. Nature. 2012;485(7396):119–22. Epub 20120415. doi: 10.1038/nature11001 . [DOI] [PubMed] [Google Scholar]
  • 4.Hayashi KI, Arai K, Aoi Y, Tanaka Y, Hira H, Guo R, et al. The main oxidative inactivation pathway of the plant hormone auxin. Nat Commun. 2021;12(1):6752. Epub 20211122. doi: 10.1038/s41467-021-27020-1 ; PubMed Central PMCID: PMC8608799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Casanova-Saez R, Mateo-Bonmati E, Ljung K. Auxin Metabolism in Plants. Cold Spring Harb Perspect Biol. 2021;13(3). Epub 20210301. doi: 10.1101/cshperspect.a039867 ; PubMed Central PMCID: PMC7919392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Zhao Y, Christensen SK, Fankhauser C, Cashman JR, Cohen JD, Weigel D, et al. A role for flavin monooxygenase-like enzymes in auxin biosynthesis. Science. 2001;291(5502):306–9. doi: 10.1126/science.291.5502.306 . [DOI] [PubMed] [Google Scholar]
  • 7.Duca D, Lorv J, Patten CL, Rose D, Glick BR. Indole-3-acetic acid in plant-microbe interactions. Antonie Van Leeuwenhoek. 2014;106(1):85–125. Epub 20140121. doi: 10.1007/s10482-013-0095-y . [DOI] [PubMed] [Google Scholar]
  • 8.Ludwig-Muller J. Bacteria and fungi controlling plant growth by manipulating auxin: balance between development and defense. J Plant Physiol. 2015;172:4–12. Epub 20141119. doi: 10.1016/j.jplph.2014.01.002 . [DOI] [PubMed] [Google Scholar]
  • 9.Van Puyvelde S, Cloots L, Engelen K, Das F, Marchal K, Vanderleyden J, et al. Transcriptome analysis of the rhizosphere bacterium Azospirillum brasilense reveals an extensive auxin response. Microb Ecol. 2011;61(4):723–8. Epub 20110222. doi: 10.1007/s00248-011-9819-6 . [DOI] [PubMed] [Google Scholar]
  • 10.Duran P, Thiergart T, Garrido-Oter R, Agler M, Kemen E, Schulze-Lefert P, et al. Microbial Interkingdom Interactions in Roots Promote Arabidopsis Survival. Cell. 2018;175(4):973–83 e14. doi: 10.1016/j.cell.2018.10.020 ; PubMed Central PMCID: PMC6218654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Zuniga A, Poupin MJ, Donoso R, Ledger T, Guiliani N, Gutierrez RA, et al. Quorum sensing and indole-3-acetic acid degradation play a role in colonization and plant growth promotion of Arabidopsis thaliana by Burkholderia phytofirmans PsJN. Mol Plant Microbe Interact. 2013;26(5):546–53. doi: 10.1094/MPMI-10-12-0241-R . [DOI] [PubMed] [Google Scholar]
  • 12.Baudoin E, Lerner A, Mirza MS, El Zemrany H, Prigent-Combaret C, Jurkevich E, et al. Effects of Azospirillum brasilense with genetically modified auxin biosynthesis gene ipdC upon the diversity of the indigenous microbiota of the wheat rhizosphere. Res Microbiol. 2010;161(3):219–26. Epub 20100204. doi: 10.1016/j.resmic.2010.01.005 . [DOI] [PubMed] [Google Scholar]
  • 13.Chaiharn M, Lumyong S. Screening and optimization of indole-3-acetic acid production and phosphate solubilization from rhizobacteria aimed at improving plant growth. Curr Microbiol. 2011;62(1):173–81. Epub 20100616. doi: 10.1007/s00284-010-9674-6 . [DOI] [PubMed] [Google Scholar]
  • 14.Finkel OM, Salas-Gonzalez I, Castrillo G, Conway JM, Law TF, Teixeira P, et al. A single bacterial genus maintains root growth in a complex microbiome. Nature. 2020;587(7832):103–8. Epub 20200930. doi: 10.1038/s41586-020-2778-7 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Leveau JH, Gerards S. Discovery of a bacterial gene cluster for catabolism of the plant hormone indole 3-acetic acid. FEMS Microbiol Ecol. 2008;65(2):238–50. Epub 20080118. doi: 10.1111/j.1574-6941.2008.00436.x . [DOI] [PubMed] [Google Scholar]
  • 16.Laird TS, Flores N, Leveau JHJ. Bacterial catabolism of indole-3-acetic acid. Appl Microbiol Biotechnol. 2020;104(22):9535–50. Epub 20201010. doi: 10.1007/s00253-020-10938-9 . [DOI] [PubMed] [Google Scholar]
  • 17.Sun SL, Yang WL, Fang WW, Zhao YX, Guo L, Dai YJ. The Plant Growth-Promoting Rhizobacterium Variovorax boronicumulans CGMCC 4969 Regulates the Level of Indole-3-Acetic Acid Synthesized from Indole-3-Acetonitrile. Appl Environ Microbiol. 2018;84(16). Epub 20180801. doi: 10.1128/AEM.00298-18 ; PubMed Central PMCID: PMC6070764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Conway JM, Walton WG, Salas-Gonzalez I, Law TF, Lindberg CA, Crook LE, et al. Diverse MarR bacterial regulators of auxin catabolism in the plant microbiome. Nat Microbiol. 2022;7(11):1817–33. Epub 20221020. doi: 10.1038/s41564-022-01244-3 ; PubMed Central PMCID: PMC9613470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Berntsson RP, Smits SH, Schmitt L, Slotboom DJ, Poolman B. A structural classification of substrate-binding proteins. FEBS Lett. 2010;584(12):2606–17. Epub 20100420. doi: 10.1016/j.febslet.2010.04.043 . [DOI] [PubMed] [Google Scholar]
  • 20.Scheepers GH, Lycklama ANJA, Poolman B. An updated structural classification of substrate-binding proteins. FEBS Lett. 2016;590(23):4393–401. Epub 20161023. doi: 10.1002/1873-3468.12445 . [DOI] [PubMed] [Google Scholar]
  • 21.Petersson SV, Johansson AI, Kowalczyk M, Makoveychuk A, Wang JY, Moritz T, et al. An auxin gradient and maximum in the Arabidopsis root apex shown by high-resolution cell-specific analysis of IAA distribution and synthesis. Plant Cell. 2009;21(6):1659–68. Epub 20090602. doi: 10.1105/tpc.109.066480 ; PubMed Central PMCID: PMC2714926. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Greenhut IV, Slezak BL, Leveau JHJ. iac Gene Expression in the Indole-3-Acetic Acid-Degrading Soil Bacterium Enterobacter soli LF7. Appl Environ Microbiol. 2018;84(19). Epub 20180917. doi: 10.1128/AEM.01057-18 ; PubMed Central PMCID: PMC6146976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Brandl MT, Lindow SE. Contribution of indole-3-acetic acid production to the epiphytic fitness of erwinia herbicola. Appl Environ Microbiol. 1998;64(9):3256–63. doi: 10.1128/AEM.64.9.3256-3263.1998 ; PubMed Central PMCID: PMC106718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Tan K, Chang C, Cuff M, Osipiuk J, Landorf E, Mack JC, et al. Structural and functional characterization of solute binding proteins for aromatic compounds derived from lignin: p-coumaric acid and related aromatic acids. Proteins. 2013;81(10):1709–26. Epub 20130723. doi: 10.1002/prot.24305 ; PubMed Central PMCID: PMC4095797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Chandravanshi M, Samanta R, Kanaujia SP. Structural and thermodynamic insights into the novel dinucleotide-binding protein of ABC transporter unveils its moonlighting function. FEBS J. 2021;288(15):4614–36. Epub 20210302. doi: 10.1111/febs.15774 . [DOI] [PubMed] [Google Scholar]
  • 26.Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596(7873):583–9. Epub 20210715. doi: 10.1038/s41586-021-03819-2 ; PubMed Central PMCID: PMC8371605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Dhindwal S, Gomez-Gil L, Neau DB, Pham TT, Sylvestre M, Eltis LD, et al. Structural Basis of the Enhanced Pollutant-Degrading Capabilities of an Engineered Biphenyl Dioxygenase. J Bacteriol. 2016;198(10):1499–512. Epub 20160428. doi: 10.1128/JB.00952-15 ; PubMed Central PMCID: PMC4859605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Ferraro DJ, Gakhar L, Ramaswamy S. Rieske business: structure-function of Rieske non-heme oxygenases. Biochem Biophys Res Commun. 2005;338(1):175–90. Epub 20050908. doi: 10.1016/j.bbrc.2005.08.222 . [DOI] [PubMed] [Google Scholar]
  • 29.Correll CC, Batie CJ, Ballou DP, Ludwig ML. Phthalate dioxygenase reductase: a modular structure for electron transfer from pyridine nucleotides to [2Fe-2S]. Science. 1992;258(5088):1604–10. doi: 10.1126/science.1280857 . [DOI] [PubMed] [Google Scholar]
  • 30.Gassner GT, Ludwig ML, Gatti DL, Correll CC, Ballou DP. Structure and mechanism of the iron-sulfur flavoprotein phthalate dioxygenase reductase. FASEB J. 1995;9(14):1411–8. doi: 10.1096/fasebj.9.14.7589982 . [DOI] [PubMed] [Google Scholar]
  • 31.Szkop M, Sikora P, Orzechowski S. A novel, simple, and sensitive colorimetric method to determine aromatic amino acid aminotransferase activity using the Salkowski reagent. Folia Microbiol (Praha). 2012;57(1):1–4. Epub 20111201. doi: 10.1007/s12223-011-0089-y ; PubMed Central PMCID: PMC3297745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Ashikawa Y, Fujimoto Z, Noguchi H, Habe H, Omori T, Yamane H, et al. Electron transfer complex formation between oxygenase and ferredoxin components in Rieske nonheme iron oxygenase system. Structure. 2006;14(12):1779–89. doi: 10.1016/j.str.2006.10.004 . [DOI] [PubMed] [Google Scholar]
  • 33.Zhao Z, Zhang Y, Liu X, Zhang X, Liu S, Yu X, et al. A role for a dioxygenase in auxin metabolism and reproductive development in rice. Dev Cell. 2013;27(1):113–22. Epub 20131003. doi: 10.1016/j.devcel.2013.09.005 . [DOI] [PubMed] [Google Scholar]
  • 34.Maqbool A, Horler RS, Muller A, Wilkinson AJ, Wilson KS, Thomas GH. The substrate-binding protein in bacterial ABC transporters: dissecting roles in the evolution of substrate specificity. Biochem Soc Trans. 2015;43(5):1011–7. doi: 10.1042/BST20150135 . [DOI] [PubMed] [Google Scholar]
  • 35.Fitzpatrick CR, Copeland J, Wang PW, Guttman DS, Kotanen PM, Johnson MTJ. Assembly and ecological function of the root microbiome across angiosperm plant species. Proc Natl Acad Sci U S A. 2018;115(6):E1157–E65. Epub 20180122. doi: 10.1073/pnas.1717617115 ; PubMed Central PMCID: PMC5819437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Thiergart T, Duran P, Ellis T, Vannier N, Garrido-Oter R, Kemen E, et al. Root microbiota assembly and adaptive differentiation among European Arabidopsis populations. Nat Ecol Evol. 2020;4(1):122–31. Epub 20191223. doi: 10.1038/s41559-019-1063-3 . [DOI] [PubMed] [Google Scholar]
  • 37.Schuck P. On the analysis of protein self-association by sedimentation velocity analytical ultracentrifugation. Anal Biochem. 2003;320(1):104–24. doi: 10.1016/s0003-2697(03)00289-6 . [DOI] [PubMed] [Google Scholar]
  • 38.Schuck P, Perugini MA, Gonzales NR, Howlett GJ, Schubert D. Size-distribution analysis of proteins by analytical ultracentrifugation: strategies and application to model systems. Biophys J. 2002;82(2):1096–111. doi: 10.1016/S0006-3495(02)75469-6 ; PubMed Central PMCID: PMC1301916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Petoukhov MV, Franke D, Shkumatov AV, Tria G, Kikhney AG, Gajda M, et al. New developments in the ATSAS program package for small-angle scattering data analysis. J Appl Cryst. 2012;45(Pt 2):342–50. Epub 20120315. doi: 10.1107/S0021889812007662 ; PubMed Central PMCID: PMC4233345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Manalastas-Cantos K, Konarev PV, Hajizadeh NR, Kikhney AG, Petoukhov MV, Molodenskiy DS, et al. ATSAS 3.0: expanded functionality and new tools for small-angle scattering data analysis. J Appl Cryst. 2021;54(Pt 1):343–55. Epub 20210201. doi: 10.1107/S1600576720013412 ; PubMed Central PMCID: PMC7941305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Konarev PV, Volkov VV, Sokolova AV, Koch MHJ, Svergun DI. PRIMUS: a Windows PC-based system for small-angle scattering data analysis. J Appl Cryst. 2003;36(5):1277–82. doi: 10.1107/S0021889803012779 [DOI] [Google Scholar]
  • 42.Svergun D. Determination of the regularization parameter in indirect-transform methods using perceptual criteria. J Appl Cryst. 1992;25(4):495–503. doi: 10.1107/S0021889892001663 [DOI] [Google Scholar]
  • 43.Svergun DI. Restoring low resolution structure of biological macromolecules from solution scattering using simulated annealing. Biophys J. 1999;76(6):2879–86. doi: 10.1016/S0006-3495(99)77443-6 ; PubMed Central PMCID: PMC1300260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Potterton L, Agirre J, Ballard C, Cowtan K, Dodson E, Evans PR, et al. CCP4i2: the new graphical user interface to the CCP4 program suite. Acta Crystallogr D Struct Biol. 2018;74(Pt 2):68–84. Epub 20180201. doi: 10.1107/S2059798317016035 ; PubMed Central PMCID: PMC5947771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta Crystallogr D Biol Crystallogr. 2010;66(Pt 4):486–501. Epub 20100324. doi: 10.1107/S0907444910007493 ; PubMed Central PMCID: PMC2852313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Adams PD, Grosse-Kunstleve RW, Hung LW, Ioerger TR, McCoy AJ, Moriarty NW, et al. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr D Biol Crystallogr. 2002;58(Pt 11):1948–54. Epub 20021021. doi: 10.1107/s0907444902016657 . [DOI] [PubMed] [Google Scholar]
  • 47.Afonine PV, Grosse-Kunstleve RW, Echols N, Headd JJ, Moriarty NW, Mustyakimov M, et al. Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr D Biol Crystallogr. 2012;68(Pt 4):352–67. Epub 20120316. doi: 10.1107/S0907444912001308 ; PubMed Central PMCID: PMC3322595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455–61. doi: 10.1002/jcc.21334 ; PubMed Central PMCID: PMC3041641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Eastman P, Swails J, Chodera JD, McGibbon RT, Zhao Y, Beauchamp KA, et al. OpenMM 7: Rapid development of high performance algorithms for molecular dynamics. PLoS Comput Biol. 2017;13(7):e1005659. Epub 20170726. doi: 10.1371/journal.pcbi.1005659 ; PubMed Central PMCID: PMC5549999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Roe DR, Cheatham TE 3rd. PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data. J Chem Theory Comput. 2013;9(7):3084–95. Epub 20130625. doi: 10.1021/ct400341p . [DOI] [PubMed] [Google Scholar]
  • 51.Maier JA, Martinez C, Kasavajhala K, Wickstrom L, Hauser KE, Simmerling C. ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB. J Chem Theory Comput. 2015;11(8):3696–713. Epub 20150723. doi: 10.1021/acs.jctc.5b00255 ; PubMed Central PMCID: PMC4821407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Zivanov J, Nakane T, Forsberg BO, Kimanius D, Hagen WJ, Lindahl E, et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. Elife. 2018;7. Epub 20181109. doi: 10.7554/eLife.42166 ; PubMed Central PMCID: PMC6250425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Zheng SQ, Palovcak E, Armache JP, Verba KA, Cheng Y, Agard DA. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat Methods. 2017;14(4):331–2. Epub 20170227. doi: 10.1038/nmeth.4193 ; PubMed Central PMCID: PMC5494038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Zhang K. Gctf: Real-time CTF determination and correction. J Struct Biol. 2016;193(1):1–12. Epub 20151119. doi: 10.1016/j.jsb.2015.11.003 ; PubMed Central PMCID: PMC4711343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Punjani A, Rubinstein JL, Fleet DJ, Brubaker MA. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat Methods. 2017;14(3):290–6. Epub 20170206. doi: 10.1038/nmeth.4169 . [DOI] [PubMed] [Google Scholar]
  • 56.Liebschner D, Afonine PV, Baker ML, Bunkoczi G, Chen VB, Croll TI, et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr D Struct Biol. 2019;75(Pt 10):861–77. Epub 20191002. doi: 10.1107/S2059798319011471 ; PubMed Central PMCID: PMC6778852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Afonine PV, Klaholz BP, Moriarty NW, Poon BK, Sobolev OV, Terwilliger TC, et al. New tools for the analysis and validation of cryo-EM maps and atomic models. Acta Crystallogr D Struct Biol. 2018;74(Pt 9):814–40. Epub 20180903. doi: 10.1107/S2059798318009324 ; PubMed Central PMCID: PMC6130467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr. 2010;66(Pt 2):213–21. Epub 20100122. doi: 10.1107/S0907444909052925 ; PubMed Central PMCID: PMC2815670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Williams CJ, Headd JJ, Moriarty NW, Prisant MG, Videau LL, Deis LN, et al. MolProbity: More and better reference data for improved all-atom structure validation. Protein Sci. 2018;27(1):293–315. Epub 20171127. doi: 10.1002/pro.3330 ; PubMed Central PMCID: PMC5734394. [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Richard Hodge

19 Dec 2022

Dear Dr Yu,

Thank you for submitting your manuscript entitled "Molecular Mechanism for Bacterial Degradation of Plant Hormone Auxin" for consideration as a Research Article by PLOS Biology.

Your manuscript has now been evaluated by the PLOS Biology editorial staff, as well as by an academic editor with relevant expertise, and I am writing to let you know that we would like to send your submission out for external peer review.

However, before we can send your manuscript to reviewers, we need you to complete your submission by providing the metadata that is required for full assessment. To this end, please login to Editorial Manager where you will find the paper in the 'Submissions Needing Revisions' folder on your homepage. Please click 'Revise Submission' from the Action Links and complete all additional questions in the submission questionnaire.

Once your full submission is complete, your paper will undergo a series of checks in preparation for peer review. After your manuscript has passed the checks it will be sent out for review. To provide the metadata for your submission, please Login to Editorial Manager (https://www.editorialmanager.com/pbiology) within two working days, i.e. by Dec 21 2022 11:59PM.

If your manuscript has been previously peer-reviewed at another journal, PLOS Biology is willing to work with those reviews in order to avoid re-starting the process. Submission of the previous reviews is entirely optional and our ability to use them effectively will depend on the willingness of the previous journal to confirm the content of the reports and share the reviewer identities. Please note that we reserve the right to invite additional reviewers if we consider that additional/independent reviewers are needed, although we aim to avoid this as far as possible. In our experience, working with previous reviews does save time.

If you would like us to consider previous reviewer reports, please edit your cover letter to let us know and include the name of the journal where the work was previously considered and the manuscript ID it was given. In addition, please upload a response to the reviews as a 'Prior Peer Review' file type, which should include the reports in full and a point-by-point reply detailing how you have or plan to address the reviewers' concerns.

During the process of completing your manuscript submission, you will be invited to opt-in to posting your pre-review manuscript as a bioRxiv preprint. Visit http://journals.plos.org/plosbiology/s/preprints for full details. If you consent to posting your current manuscript as a preprint, please upload a single Preprint PDF.

Feel free to email us at plosbiology@plos.org if you have any queries relating to your submission.

Kind regards,

Richard

Richard Hodge, PhD

Associate Editor, PLOS Biology

rhodge@plos.org

PLOS

Empowering researchers to transform science

Carlyle House, Carlyle Road, Cambridge, CB4 3DN, United Kingdom

ORCiD I plosbio.org I @PLOSBiology I Blog

California (U.S.) corporation #C2354500, based in San Francisco

Decision Letter 1

Richard Hodge

9 Feb 2023

Dear Dr Yu,

Thank you for your patience while your manuscript "Molecular Mechanism for Bacterial Degradation of Plant Hormone Auxin" was peer-reviewed at PLOS Biology. Please accept my apologies for the delays that you have experienced during the peer review process. Your manuscript has now been evaluated by the PLOS Biology editors, an Academic Editor with relevant expertise, and by three independent reviewers.

In light of the reviews, which you will find at the end of this email, we would like to invite you to revise the work to thoroughly address the reviewers' reports.

As you will see, the reviewers think the study is interesting and well done, but raise concerns about the lack of comparison with a previous study in Nature Microbiology that recently characterized an iac/iad auxin degradation locus (Conway et al, 2022, PMID 36266335), as well as noting that different nomenclature appears to be used to define the operon (adg vs iac). I have provided some specific comments from the Academic Editor on this point below the reviewer reports, and we ask that you please clarify whether your study is focusing on the same operon where a different reaction and degradation product are described, or whether the paper focuses on a distinct operon. In addition, the reviewers also ask for several additional control experiments, including a mutational validation in AdgA to provide further support for the IAA binding model and using PAA in the ITC assays to strengthen the conclusions regarding substrate specificity.

Given the extent of revision needed, we cannot make a decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is likely to be sent for further evaluation by all or a subset of the reviewers.

We expect to receive your revised manuscript within 3 months. Please email us (plosbiology@plos.org) if you have any questions or concerns, or would like to request an extension.

At this stage, your manuscript remains formally under active consideration at our journal; please notify us by email if you do not intend to submit a revision so that we may withdraw it.

**IMPORTANT - SUBMITTING YOUR REVISION**

Your revisions should address the specific points made by each reviewer. Please submit the following files along with your revised manuscript:

1. A 'Response to Reviewers' file - this should detail your responses to the editorial requests, present a point-by-point response to all of the reviewers' comments, and indicate the changes made to the manuscript.

*NOTE: In your point-by-point response to the reviewers, please provide the full context of each review. Do not selectively quote paragraphs or sentences to reply to. The entire set of reviewer comments should be present in full and each specific point should be responded to individually, point by point.

You should also cite any additional relevant literature that has been published since the original submission and mention any additional citations in your response.

2. In addition to a clean copy of the manuscript, please also upload a 'track-changes' version of your manuscript that specifies the edits made. This should be uploaded as a "Revised Article with Changes Highlighted" file type.

*Re-submission Checklist*

When you are ready to resubmit your revised manuscript, please refer to this re-submission checklist: https://plos.io/Biology_Checklist

To submit a revised version of your manuscript, please go to https://www.editorialmanager.com/pbiology/ and log in as an Author. Click the link labelled 'Submissions Needing Revision' where you will find your submission record.

Please make sure to read the following important policies and guidelines while preparing your revision:

*Published Peer Review*

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details:

https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/

*PLOS Data Policy*

Please note that as a condition of publication PLOS' data policy (http://journals.plos.org/plosbiology/s/data-availability) requires that you make available all data used to draw the conclusions arrived at in your manuscript. If you have not already done so, you must include any data used in your manuscript either in appropriate repositories, within the body of the manuscript, or as supporting information (N.B. this includes any numerical values that were used to generate graphs, histograms etc.). For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5

*Blot and Gel Data Policy*

We require the original, uncropped and minimally adjusted images supporting all blot and gel results reported in an article's figures or Supporting Information files. We will require these files before a manuscript can be accepted so please prepare them now, if you have not already uploaded them. Please carefully read our guidelines for how to prepare and upload this data: https://journals.plos.org/plosbiology/s/figures#loc-blot-and-gel-reporting-requirements

*Protocols deposition*

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Thank you again for your submission to our journal. We hope that our editorial process has been constructive thus far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Richard

Richard Hodge, PhD

Associate Editor, PLOS Biology

rhodge@plos.org

------------------------------------

REVIEWS:

Reviewer #1: The manuscript by Ma, et al. describes the ligand binding, structure and activity of proteins from the Variovorax auxin-degradation operon responsible for IAA binding and degradation. The authors performed crystallization studies and enzymatic assays to demonstrate IAA binding and enzymatic activity by AdgB, I, J and H. The degradation product of IAA catalysed by AdI/H/J was further characterized by mass spectrometry. The genes responsible for IAA degradation were then tested in E. coli and IAA degradation tested. Understanding the enzymes involved in IAA degradation and the crosstalk between plants and bacteria is of broad interest to the plant biology community.

Certain points need to be addressed to better clarify the results of the manuscript and to put it into a broader context of what is known about IAA degrading bacteria-

The results need to be discussed in context of recent literature, in particular Conway, et al. 2022 https://doi.org/10.1038/s41564-022-01244-3 The catalytic mechanisms and different reaction products should be explained. As the nomenclature is different, it is difficult for the reader to follow. Are the authors using V. paradoxus in this study? Is this the same operon as described in Conway, et al.?

I am unclear as to the applications the authors envision for this operon in engineering the rhizosphere microbiome. This would be making transgenic soil bacteria to alter RGI?

ITC measurements need s.d. or s.e.m. How many times were these measurements performed? For thermal shift assays in Fig. 1 the error bars are very faint and hard to see.

Given that AdgB is not in complex with IAA, docking studies were done. SAXS could be used to determine if AdgB adopts closed conformation upon IAA binding as co-crystallisation and soaking did not work.

Mutations of AdgA to bind IAA based on the structural and modelling studies of AdgB would be interesting to further support the model for IAA specific binding.

The structures in Fig.3 examine both X-ray and EM structures with the X-ray structure of AdgH/I in the apo form and the EM structure in the IAA bound form. A larger portion of the EM map should be shown around the active site and more detailed comparison of the conformation of the side chains in the apo and ligand bound form described. How well-positioned are the side chains in the EM model vs. the X-ray structure?

Fig. 4 -The schematic illustration is too small and uninterpretable. It is unclear where the electron is coming from and where it is going and how the reaction is catalysed.

For the crystal tables, please provide CC1/2, Ramachandran statistics should be included. The clash scores and R factors are quite high for 7YLT. Is this structure fully refined? Also there seem to be a lot of RSTZ outliers for all structures.

Supp Fig. 3 The SAXS experimental curve and theoretical model are very different. The fit looks extremely poor, especially at high q range, can the authors address this?

Reviewer #2: This manuscript is very straightforward, and summarizes an impressive amount of work, including the biochemical characterization of three different enzymes involved in IAA transport and metabolism. Overall, the claims are well supported. The findings are important, as they increase our understanding of how microbes can alter the concentration of the plant hormone IAA, an auxin, in plant roots and the rhizosphere.

The manuscript is succinctly written, and in some places additional key information and details need to be provided so assist the readers in understanding the experiments and to strengthen the rationale for the work. Additionally, I believe use of the term "degradation" is often inappropriately used, and thus confusing to the reader.

Scientific comments and concerns

1. An IAA degradation locus referred to as iad has been recently described (Conway et al, 2022 Nature Microbiology). Is the adg locus discussed here distinct from that locus?

2. The naturally occurring auxin phenyl acetic acid (PAA) should be included in the ITC experiments investigating substrate specificity. This is important to examine before the authors can claim that the protein has specificity for bicyclic compounds.

3. I was confused by the use of the term degradation, when the authors actually mean transformation (or conversion) of IAA into oxIAA, which is presumably inactive, but still present in the cell.

4. It seems the authors believe that the SBP proteins are required for entry of IAA into the cell. However, at acidic pH (e.g. pH 5.8) much of the IAA is protonated, and thus may be able to diffuse across the membrane without the aid of transporters (at least this is what plant biologists who study IAA assume). It would be very interesting to test this idea in a Varivorax adgB mutant. This question may be beyond the scope of this manuscript, but could be addressed in future studies.

5. The question about pH and entry of IAA into bacteria cells arose when I was considering the experiment shown in Fig. 6 (ecotpic expression of adg genes in E. coli). Presumably these experiments were done in pH7 media, but it would be helpful to confirm that the LB used in the IAA degradation assays was at pH 7 .

6. A control is missing for the experiment shown in Fig. 4 B. How can we ensure that the colormetric change does not occur spontaneously given enough time? A "no enzyme added" negative control is needed. Also, what is the time frame shown for the panel on the right, compared to the graph on the left?

7. More information regarding what is shown on the y axes in fig. 4 would be helpful.

Editorial comments

Introduction:

1. I believe the PAA, a natural and active form of auxin, is more abundant than IAA in many plants.

2. Is reference 9 the appropriate citation for the general statement that "most rhizobacteria are found capable of producing IAA"? Referencing a review article would be more suitable.

8. An IAA degradation locus referred to as iad has been recently described (Conway et al, 2022 Nature Microbiology). Are the adg genes here distinct from that locus?

9. Is it appropriate to refer to conversion of IAA to oxIAA as degradation? I believe the term "inactivation" might be more appropriately used throughout the manuscript, until the discussion section, when a larger picture is provided.

10. Figure 5 legend:

a. panel A- it would be helpful to indicate the color of the traces for before and after the transformation

b. Panel c: what concentration of compounds are used in the experiment shown?

Results

11. Page 4, line the term "predicted" should be used when referring to products of genes that have not been characterized yet. The adg operon IS PREDICTED to encode….

Methods:

12. The Genbank accession numbers should be provided so that readers can analyze the genes/proteins

Reviewer #3: This study builds on an earlier report by Finkel et al., 2020, which defined an auxin (IAA) degradation locus in the bacterium Variovorax paradoxus. Here the authors define (1) the structure and auxin binding mechanism for the ABC transporter solute binding protein AdgB and (2) a structure of an AdgH/AdgI non-heme Rieske dioxygenase complex. The authors further demonstrate that AdgH/I/J can catalyze IAA degradation to oxIAA. Overall, this is a well designed/executed study that combines quantitative biochemistry, structural biology and enzymology to characterize a novel bacterial IAA degradation pathway. The crystal and cryoEM structure show good sterochemistry and refinement statistics. As a non-expert in this field, I had however some difficulties to compare this work to earlier studies. In addition, there are some minor technical issues worth considering. I will summarize my points below:

1. MAJOR: A recent study by Conway et al, 2022 (https://doi.org/10.1038/s41564-022-01244-3) reported the gene products iadCDE as the minimal functional unit required for IAA degradation in Variovorax, and the regulation of root growth inhibition of a plant model (compare Fig. 1c in this study). Do the authors use the same nomenclature in this work (Fig. 1A) and if so, does that mean that there are two auxin degradation pathways encoded in Variovorax gene cluster, one represented by iad/adgCDE and one by adgH/I/J? If so, why are iadD and iadE necessary and sufficient for IAA degradation and root growth inhibition mediated by Variovorax (Conway et al, 2022, Fig. 1d)?

2. MAJOR: I understand that iadB/adgB is the bacterial ABC transporter enabling IAA uptake into the cytoplasm of Variovorax. Assuming that all other degradation enzymes are present in the cytoplasm, does that mean that adgB is essential for both the iadC/D/E and the adgH/I/J pathways? Has this been experimentally tested, for example by genetic epistasis analysis?

3. MINOR: As anticipated, AdgB could engage IAA with nanomolar affinity, whereas no obvious binding was detected for AdgA and IAA. Why was it anticipated that AdgA would not bind IAA? This could be discussed later in the text, when the authors compare the degree of conservation of the putative IAA binding pocket in both proteins.

4. MAJOR: Fig. 1C, can the authors rationalize the bimodal binding behavior for recombinant AdgB in the ITC assay? The structure seems to indicate a single IAA binding site?

5. MAJOR: Conway et al, 2022 et al reported iad/C/D/E to form an IAA degradation complex. Have these proteins been tested in the ITC assays shown in Supplementary Fig. 1, and if so, why was no binding detected? It seems that MarR domains, that show high affinity IAA binding (Kd ~0.3 uM) (Conway et al. 2022) were excluded from the analysis in Fig. S1? This should be mentioned in the figure legend.

6. MAJOR: In the Figure 5, the authors nicely demonstrate that AdgH/I/J can catalyze IAA oxidation. Can these data be integrated with the metabolic analysis by Conway et al, 2022, Fig. 4? Could this imply that iadCDE and adgHIJ are part of one degradation pathway, and that adgHIJ may use 2-hydroxy-indole-3-acetic acid or dioxindole-3-acetic acid (DOAA) as substrates in vivo? Please clarify.

7. MINOR: Figure 5a/Figure S7. Could the HPLC buffer system or column be optimized to obtain a sharper peak for IAA?

8. MAJOR: Fig. 5. I would recommend to determine rate constants for the different substrates.

9. MINOR: Fig. 6D may need to be revised depending on the outcome of the analysis on point 6 (see above)

10. MINOR: Introduction: "Elucidating the underlying mechanism of bacterial IAA degradation would help to maximize the beneficial effects of auxin degradation for ecological agriculture." How would that be achieved?

11. MINOR: Introduction: "Dissecting and defining the functional mechanism of the adg operon is therefore of significant importance for the applications in ecological and stress agricultures." What type of application exist that make use of bacterial IAA degradation, please specify.

*COMMENTS FROM THE ACADEMIC EDITOR*

I agree with the reviewers that the lack of comparison the Conway is a major weakness and it isn’t clear where the “adg” nomenclature/operon (instead “iac” in the Finkle 2020 paper and iac/iad in the Conway 2022 paper) came from. Similarly, the operon structures in Conway seems a bit different than in this paper so I’m wondering if these are distinct operons. However, if that’s the case, then the authors of this paper should clearly state how they decided to study the adg operon and it’s demonstrated role in auxin degradation (and if it is different from or the same as iac or iad).

Futhermore, the IAA degradation reactions described are different. The Conway paper describes that the iac operon breaks down IAA through DOAA to catechol while the iad locus converts IAA to anthranilic acid. In this paper, they describe oxIAA as the next step in degradation by the adg degrading operon. Either Ma et al. are describing the same operon but found a different reaction and degradation product or they’re describing a distinct operon suggesting 3 Variovorax degrading pathways. Importantly, I couldn’t find the species or strain listed anywhere in the materials and methods so it’s not clear if this is the same strain. This definitely needs to be clarified and either outcome (two mechanisms, or inconsistency with previous papers) should be clarified.

Decision Letter 2

Richard Hodge

1 Jun 2023

Dear Dr Yu,

Thank you for your patience while we considered your revised manuscript "Molecular Mechanism for Bacterial Degradation of Plant Hormone Auxin" for publication as a Research Article at PLOS Biology. This revised version of your manuscript has been evaluated by the PLOS Biology editors and the Academic Editor.

Based on our Academic Editor's assessment of your revision, I am pleased to say that we are likely to accept this manuscript for publication, provided you satisfactorily address the following data and other policy-related requests that I have provided below (A-F):

(A) We would like to suggest the following modification to the title:

“Structural and biochemical characterization of the key components of an auxin-degradation operon from the rhizosphere bacterium Variovorax”

(B) You may be aware of the PLOS Data Policy, which requires that all data be made available without restriction: http://journals.plos.org/plosbiology/s/data-availability. For more information, please also see this editorial: http://dx.doi.org/10.1371/journal.pbio.1001797

Note that we do not require all raw data. Rather, we ask that all individual quantitative observations that underlie the data summarized in the figures and results of your paper be made available in one of the following forms:

- Supplementary files (e.g., excel). Please ensure that all data files are uploaded as 'Supporting Information' and are invariably referred to (in the manuscript, figure legends, and the Description field when uploading your files) using the following format verbatim: S1 Data, S2 Data, etc. Multiple panels of a single or even several figures can be included as multiple sheets in one excel file that is saved using exactly the following convention: S1_Data.xlsx (using an underscore).

- Deposition in a publicly available repository. Please also provide the accession code or a reviewer link so that we may view your data before publication.

Regardless of the method selected, please ensure that you provide the individual numerical values that underlie the summary data displayed in the following figure panels as they are essential for readers to assess your analysis and to reproduce it:

Figure 1C-E, 2D-E, 3A, 3F, 4A-B, 4D, 4F, 5A-B, 6B-C, S1B-E, S2A-B, S3D, S4A, S8B, S11

NOTE: the numerical data provided should include all replicates AND the way in which the plotted mean and errors were derived (it should not present only the mean/average values).

(C) Thank you for depositing the structural data in the PDB (7YLT, 7YLS, 7YLR, 8H2T) and EMDB databases (EMD-34443). However, I note that the data is currently on hold. We ask that you please make this data publicly available before publication.

(D) Please also ensure that each of the relevant figure legends in your manuscript include information on *WHERE THE UNDERLYING DATA CAN BE FOUND*, and ensure your supplemental data file/s has a legend.

(E) We require the original, uncropped and minimally adjusted images supporting all blot and gel results reported in the following Figures:

Figure S4B

We will require these files before a manuscript can be accepted so please prepare and upload them now. Please carefully read our guidelines for how to prepare and upload this data: https://journals.plos.org/plosbiology/s/figures#loc-blot-and-gel-reporting-requirements

(F) Please ensure that your Data Statement in the submission system accurately describes where your data can be found and is in final format, as it will be published as written there. This includes referencing where the underlying data can be found in the Supplementary Information.

-----------------------------------------

As you address these items, please take this last chance to review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the cover letter that accompanies your revised manuscript.

We expect to receive your revised manuscript within two weeks.

To submit your revision, please go to https://www.editorialmanager.com/pbiology/ and log in as an Author. Click the link labelled 'Submissions Needing Revision' to find your submission record. Your revised submission must include the following:

- a cover letter that should detail your responses to any editorial requests, if applicable, and whether changes have been made to the reference list

- a Response to Reviewers file that provides a detailed response to the reviewers' comments (if applicable)

- a track-changes file indicating any changes that you have made to the manuscript.

NOTE: If Supporting Information files are included with your article, note that these are not copyedited and will be published as they are submitted. Please ensure that these files are legible and of high quality (at least 300 dpi) in an easily accessible file format. For this reason, please be aware that any references listed in an SI file will not be indexed. For more information, see our Supporting Information guidelines:

https://journals.plos.org/plosbiology/s/supporting-information

*Published Peer Review History*

Please note that you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details:

https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/

*Press*

Should you, your institution's press office or the journal office choose to press release your paper, please ensure you have opted out of Early Article Posting on the submission form. We ask that you notify us as soon as possible if you or your institution is planning to press release the article.

*Protocols deposition*

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please do not hesitate to contact me should you have any questions.

Kind regards,

Richard

Richard Hodge, PhD

Associate Editor, PLOS Biology

rhodge@plos.org

PLOS

Empowering researchers to transform science

Carlyle House, Carlyle Road, Cambridge, CB4 3DN, United Kingdom

ORCiD I plosbio.org I @PLOSBiology I Blog

California (U.S.) corporation #C2354500, based in San Francisco

Decision Letter 3

Richard Hodge

8 Jun 2023

Dear Dr Yu,

On behalf of my colleagues and the Academic Editor, Cara Haney, I am pleased to say that we can accept your manuscript for publication, provided you address any remaining formatting and reporting issues. These will be detailed in an email you should receive within 2-3 business days from our colleagues in the journal operations team; no action is required from you until then. Please note that we will not be able to formally accept your manuscript and schedule it for publication until you have completed any requested changes.

Please take a minute to log into Editorial Manager at http://www.editorialmanager.com/pbiology/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production process.

PRESS

We frequently collaborate with press offices. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximise its impact. If the press office is planning to promote your findings, we would be grateful if they could coordinate with biologypress@plos.org. If you have previously opted in to the early version process, we ask that you notify us immediately of any press plans so that we may opt out on your behalf.

We also ask that you take this opportunity to read our Embargo Policy regarding the discussion, promotion and media coverage of work that is yet to be published by PLOS. As your manuscript is not yet published, it is bound by the conditions of our Embargo Policy. Please be aware that this policy is in place both to ensure that any press coverage of your article is fully substantiated and to provide a direct link between such coverage and the published work. For full details of our Embargo Policy, please visit http://www.plos.org/about/media-inquiries/embargo-policy/.

Thank you again for choosing PLOS Biology for publication and supporting Open Access publishing. We look forward to publishing your study. 

Kind regards, 

Richard

Richard Hodge, PhD

Senior Editor, PLOS Biology

rhodge@plos.org

PLOS

Empowering researchers to transform science

Carlyle House, Carlyle Road, Cambridge, CB4 3DN, United Kingdom

ORCiD I plosbio.org I @PLOSBiology I Blog

California (U.S.) corporation #C2354500, based in San Francisco

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Interaction between Iad proteins and IAA (related to Figs 1 and 3).

    (A) Schematics for the auxin IAA-degradation (iad) operon in Variovorax paradoxus CL14. The green box highlights the 10 genes examined in the study for IAA transformation. (B) ITC measurement of IAA binding to iadk3. “ND” indicates no binding detected. (C) Thermal shift assay for iadk3 with IAA and different analogs including 4Cl-IAA, IPA, IBA, 2,4-D, and NAA. Three replicates of each TSA experiments were performed. (D) Integrated heat plots for ITC measurements of different Iad proteins binding with IAA. Measurements for proteins iadf-J and iadc with IAA are displayed. ND: no binding detected. Three or more independent measurements were performed. (E) Tm changes for Iad proteins in the presence of IAA in the thermal shift assay. Three replications of each TSA experiments were performed. While adding of IAA substantially increased the melting temperature of iadk2, no profound effects were observed for the rest. Source data for B–E can be found in S1 Data.

    (TIF)

    S2 Fig. ITC measurements of PAA to IadK2 and IadK3 (related to Figs 1 and 2).

    (A) Integrated heat plots for ITC measurement of iadk2 binding with PAA. ND: no binding detected. (B) Integrated heat plots for ITC measurements of IadK3 binding with PAA. ND: no binding detected. Two or more measurements were performed. Source data can be found in S1 Data.

    (TIF)

    S3 Fig. Comparison of IadK2, IadK3, and B-III SBPs (related to Fig 2).

    (A) The overall structure and the calculated IAA-binding pocket of iadk2 using docking and MD simulation. The L2 linker is colored in pink and the rest is in pale green. Key residues interacting with IAA are shown in sticks representation. (B) Structure of iadk3 predicted using alphafold2. The L2 linker is colored in green and the rest is in cyan. The counter residues of iadk2 involved in IAA binding iniadk3 are indicated. Residues labeled in magenta are not conserved between iadk3 and iadk2, which could be related to the IAA specificity of iadk2. (C) The closest structural homolog of iadk2 according to the Dali search. The structure of an SBP from Rhodopseudomonas palustris in complex with caffeic acid (DHC) is displayed (PDB: 4FB4). The structure containing 2 α helices in L2 belongs to the B-III subcluster of sbps. Key residues involved in substrate DHC binding are shown. (D) SAXS analysis of iadk2 complexed with IAA. Left panel: overlaid scattering pattern of the SAXS ab initio model (pink line), the theoretical scattering profiles of iadk2-IAA complex structure from MD simulation (green line) and iadk2 apo crystal structure (blue line) with SAXS scattering data of iadk2-IAA complex. The inserted panel displays the P(r) distance distributions. Right: Superposition of the ab initio SAXS model (shown as sphere) and the iadk2-IAA complex structure from MD simulation. Source data for D can be found in S1 Data. (E) Multiple sequence alignment. Sequences of iadk2, iadk3, and B-III sbps including Bp0622 (Uniprot Q7VS30), Rpb4630 (Uniprot Q2IR47), Rpd1889 (Uniprot Q139W5), and Rpa1789 (Uniprot Q6N8W4) were aligned with Clustal Omega. Essential residues for iadk2 IAA binding are marked with the filled triangles, among which the strictly conserved residues were shaded in blue, whereas moderately and less conserved residues were in yellow and light green, respectively.

    (TIF)

    S4 Fig. Biochemical and structural characterization of IadD/E complex (related to Fig 3).

    (A) ITC measurements of IAA binding to iadd or iade protein alone. ND: no binding detected. Left panel: no binding between iade and IAA was detected. Right panel: a fitted Kd value of 24 μM was obtained for iadd and IAA. Source data for A can be found in S1 Data. (B) Size-exclusion chromatograms of iadd and iade. The elution fractions from the complex peak were analyzed by SDS-PAGE gel (lower panel). Uncropped SDS-PAGE gel image can be found in S1 Raw Image. (C) Sedimentation coefficient distributions of iadd/E complex.

    (TIF)

    S5 Fig. Structural comparison of apo and IAA-bound IadD/E complex (related to Fig 3).

    (A) Electron densities and the atomic model around the active site of apo iadd/E. Densities and models around [2Fe-2S], Fe and the substrate-binding pocket were shown. (B) Electron densities and the atomic model around the active site of IAA-bound iadd/E. (C) Structural comparison of the apo and IAA-bound iadd/E structures. For clarity, 1 heterodimer subunit is displayed. The apo structure is colored in white and IAA-bound structure is colored by proteins. No profound overall conformational changes were identified between the apo and the IAA-bound structures. (D) A zoom in view of c around the active site. The side chain of H311 in IadD is relocated to accommodate the binding of IAA. Fe and coordinating residues also move slightly inwards (about 1.6 Å) following the binding of IAA.

    (TIF)

    S6 Fig. Structural comparison of IadD/E and IadC with homolog structures (related to Figs 3 and 4).

    (A) Structural comparison of iadd/E-IAA with the homolog structure (PDB: 5AEW). For clarity, a single heterodimer is displayed. Overall, the 2 structures superimposed well with each other, despite some difference in the relative orientation of the α and β subunits. The inset panel in the right shows the detailed insight into the superimposed substrate-binding pocket. (B) The homolog structure of iadc (PDR, PDB: 2PIA). The structure of PDR is also composed of 3 major domains, NBD, FBD, and fesd. Ligands FMN and the [2Fe-2S] cluster are indicated. (C) Structural comparison of IadC with PDR. PDR is colored in white and IadC is colored by domains. The arrows indicate the relative domain rotations of IadC in comparison to PDR.

    (TIF)

    S7 Fig. Cryo-EM data processing for IadD/E in complex with IAA (related to Fig 3).

    (A) A representative raw cryo-EM micrograph. Scale bar: 50 nm. (B) Representative 2D class averages. (C) 3D classification. Class 1 represent the bad reconstruction. Class 2 represents the broken protein complex. Class 3 represents the intact protein complex. (D) The final cryo-EM map of 3D refinement on Class 3. (E) Viewing distribution of the 3D refinement. (F) The Fourier shell correlation (FSC) curve of the reconstruction. The 0.143 gold standard FSC cutoff was used to determine the final resolution.

    (TIF)

    S8 Fig. Transformation of IAA and analogs by IadC-IadD/E (related to Figs 4 and 5).

    (A) Color development of IAA and analogs with the Salkowski reagent before and after treatments with iadc-iadd/E. (B) Quantification of the relative amounts of IAA or analogs before and after the oxidation reaction catalyzed by the iadc-iadd/E system. Three replications of each condition were performed. Data are presented as mean ± SEM. Source data for B can be found in S1 Data.

    (TIF)

    S9 Fig. IAA metabolite analysis by HPLC (related to Fig 5).

    The reacted mixture (RM) was analyzed with HPLC. Analyses for NADH, NAD, IAA, and oxIAA were also performed to assign the peaks.

    (TIF)

    S10 Fig. HRMS spectrum of isolated degradation product (oxIAA) from the isotopic experiment (related to Fig 5).

    The in vitro IAA degradation reaction with IadC-IadD/E was carried out in the solution containing 95% H2O18 (v/v).

    (TIF)

    S11 Fig. IAA transformation by E. coli transformed with IadK2/C/D/E genes (related to Fig 6).

    Effects of Iad proteins mutants in the in vivo IAA transformation by E. coli. Two vectors, v1 (containing genes IadK2 and IadC) and v2 (with genes IadD and IadE), were transformed to E. coli BL21(DE3) to enable IAA transformation. Mutants of IadK2 (W172L, R199A), IadD (H221A), and IadC (S61A) were tested. Little IAA conversion was observed with the empty vector without the iad genes or with the loss-of-function mutations in iadC or iadD. Source data can be found in S1 Data.

    (TIF)

    S1 Table. Crystallographic data collection and refinement statistics.

    (DOCX)

    S2 Table. Cryo-EM data collection, refinement, and validation statistics.

    (DOCX)

    S1 Data. Source data for graphs in this paper.

    (XLSX)

    S1 Raw Image. Uncropped SDS-PAGE gel image in this paper.

    (PDF)

    Attachment

    Submitted filename: Response-to-Reviewers.docx

    Attachment

    Submitted filename: Responses.docx

    Data Availability Statement

    The atomic coordinates of the structures have been deposited in the Protein Data Bank under accession codes 7YLT (IadK2), 7YLS (IadD/E), 7YLR (IadC) and 8H2T (IadD/E-IAA). The cryo-EM map of IadD/E in complex with IAA has been deposited to the Electron Microscopy Data Bank under the corresponding accession code EMD-34443. Source data are available in S1 Data.


    Articles from PLOS Biology are provided here courtesy of PLOS

    RESOURCES